Source,Indication,Bibliometric_Target,SKG_BIScore,SKG_Literature_Score,SKG_GDF15_BIScore,SKG_GDF15_Literature_Score,SKG_Total_Score,Bibliometric_Scientific_Score,Bibliometric_Market_Score,Bibliometric_Total_Score,Population,PMIDs
Ponsegromab,Mitochondrial Diseases,Mitochondrial Diseases,0,0,0,0,,85.9,64.6,150.5,45890,None
Ponsegromab,Cardiomyopathy,Cardiomyopathies,0,0,0.147442076,0.688247367,0.835689443,82.2,67.9,150.1,939598,None
Ponsegromab,Congestive heart failure,Heart Failure,0.424834346,0.324171731,0,0,0,84.9,64.2,149.1,1823483,None
Ponsegromab,Fatty liver disease,Steatotic Liver Disease (SLD) (Fatty Liver),0,0,0.157447425,0.685260244,0.842707669,68.5,77,145.5,40843500,None
Ponsegromab,Cancer cachexia,Cachexia,0.095614041,0.478070203,0.204609331,0.678377915,0.882987246,82.5,61.2,143.7,NA,None
Ponsegromab,HFpEF,"Heart Failure with preserved Ejection Fraction (HFpEF, Diastolic HF)",0.18,0,0.172601124,0.767862504,0.940463628,78,65,143,1823483,None
Ponsegromab,Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD / MAFLD / NAFLD),Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD / MAFLD / NAFLD),0,0,0,0,0,65.4,76.9,142.3,40843500,None
Ponsegromab,Myocardial Ischemia,Myocardial Ischemia,0,0,0,0,0,80.6,61.7,142.3,8851500,None
Ponsegromab,Lung cancer,Bronchogenic Carcinoma,0.061211041,0.306055203,0.178896696,0.677603432,0.856500128,71.7,69,140.7,11158792,None
Ponsegromab,Colorectal cancer,Colorectal Cancer (CRC),0.062456465,0.312282325,0.225873184,0.691100902,0.916974086,76.1,63.8,140,1374344,None
Ponsegromab,Hepato-Pancreato-Biliary Cancers,Hepato-Pancreato-Biliary Cancers,0,0,0,0,0,78.1,61.4,139.5,18356,None
Ponsegromab,Myocardial Infarction,Myocardial Infarction,0,0,0,0,0,78.2,60.6,138.8,4844922,None
Ponsegromab,Prostate cancer,Metastatic Prostate Cancer,0.025403322,0.127016612,0.210034601,0.694230626,0.904265227,63.6,73.7,137.4,9939369,None
Ponsegromab,Coronary Artery Disease (CAD),Coronary Artery Disease (CAD),0,0,0,0,0,77.2,59.4,136.6,9180605,None
Ponsegromab,Acute Myocardial Infarction (AMI),Acute Myocardial Infarction (AMI),0,0,0,0,0,75.8,59.8,135.6,4844922,None
Ponsegromab,Non-Small Cell Lung Cancer (NSCLC),Non-Small Cell Lung Cancer (NSCLC),0,0,0,0,0,71.4,62.2,133.6,689620,None
Ponsegromab,Acute Heart Failure,Acute Heart Failure,0,0,0,0,0,66.7,66.5,133.2,1823483,None
Ponsegromab,Atrial Fibrillation,Atrial Fibrillation,0,0,0,0,0,70.8,61.6,132.4,7714878,None
Ponsegromab,Acute Kidney Injury (AKI),Acute Kidney Injury (AKI),0,0,0,0,0,67,65,132.1,40170198,None
Ponsegromab,Stroke,Stroke,0,0,0,0,0,71.3,60.6,131.9,7078728,None
Ponsegromab,Gastrointestinal Cancers / Digestive System Tumors,Gastrointestinal Cancers / Digestive System Tumors,0,0,0,0,0,80.1,51.6,131.7,NA,None
Ponsegromab,Ventricular Dysfunction,Ventricular Dysfunction,0,0,0,0,0,72.2,58.8,130.9,2556982,None
Ponsegromab,Renal Insufficiency,Renal Insufficiency,0,0,0,0,0,78.7,51.8,130.6,724456,None
Ponsegromab,Cardiomegaly,Cardiomegaly,0,0,0,0,0,68.9,61.2,130,2556982,None
Ponsegromab,Chronic kidney disease,Chronic Kidney Disease (CKD),0,0,0.167650028,0.675627426,0.843277454,70.4,58.9,129.3,29317419,None
Ponsegromab,Pulmonary Arterial Hypertension (PAH),Pulmonary Arterial Hypertension (PAH),0,0,0,0,0,72.2,56.5,128.6,NA,None
Ponsegromab,Obstructive Lung Diseases,Obstructive Lung Diseases,0,0,0,0,0,70.4,58,128.4,28154789,None
Ponsegromab,Skin Cancers,Skin Cancers,0,0,0,0,0,69.9,58.5,128.4,2040603,None
Ponsegromab,Liver Diseases (Hepatology),Liver Diseases (Hepatology),0,0,0,0,0,74.9,53.3,128.2,1041348,None
Ponsegromab,Ureteral Diseases,Ureteral Diseases,0,0,0,0,0,58.3,68,126.3,5077994,None
Ponsegromab,Muscular Diseases,Muscular Diseases,0,0,0,0,0,73.8,52.4,126.2,3410860,None
Ponsegromab,Cardiac Arrhythmias,Cardiac Arrhythmias,0,0,0,0,0,69.6,56.2,125.8,2921511,None
Ponsegromab,Diabetic Kidney Disease,Diabetic Kidney Disease,0,0,0,0,0,66.1,59.6,125.7,6869750,None
Ponsegromab,Liver Fibrosis,Liver Fibrosis,0,0,0,0,0,68.8,56.8,125.6,190066,None
Ponsegromab,***Lung Cancer,***Lung Cancer,0,0,0,0,0,67.7,58,125.6,443295,None
Ponsegromab,Thoracic Cancers,Thoracic Cancers,0,0,0,0,0,67.5,57.9,125.5,443295,None
Ponsegromab,Pancreatic Cancer,Pancreatic Cancer,0.062124437,0.310622185,0.17764698,0.712129619,0.889776599,74.7,50.6,125.3,50155,None
Ponsegromab,Acute Coronary Syndrome (ACS),Acute Coronary Syndrome (ACS),0,0,0,0,0,70.1,54.9,125,NA,None
Ponsegromab,Chronic obstructive pulmonary disease,***Chronic Obstructive Pulmonary Disease (COPD),0.024004291,0.120021454,0.145883743,0.668768235,0.814651978,72,52.9,124.9,20112162,None
Ponsegromab,Hemorrhage,Hemorrhage,0,0,0,0,0,74.9,49.9,124.8,396496,None
Ponsegromab,Intestinal Neoplasms,Intestinal Neoplasms,0,0,0,0,0,76,48.7,124.7,2121796,None
Ponsegromab,Hemoglobinopathies,Hemoglobinopathies,0,0,0,0,0,66.2,58.3,124.5,64950835,None
Ponsegromab,Ovarian Diseases,Ovarian Diseases,0,0,0,0,0,71,52.4,123.4,789207,None
Ponsegromab,Structural Heart Diseases,Structural Heart Diseases,0,0,0,0,0,82.9,40.5,123.4,NA,None
Ponsegromab,Ischemic Stroke,Ischemic Stroke,0,0,0,0,0,59.6,63.3,122.9,5860973,None
Ponsegromab,Sarcopenia,Sarcopenia,0,0,0,0,0,63.6,59.2,122.8,3410860,None
Ponsegromab,Liver Cirrhosis,Liver Cirrhosis,0,0,0,0,0,68.6,54.1,122.7,1106959,None
Ponsegromab,Hematologic Malignancies,Hematologic Malignancies,0,0,0,0,0,63.4,59.1,122.5,3241352,None
Ponsegromab,Breast Cancer,Breast Cancer,0.02424421,0.121221049,0.211272216,0.675151953,0.886424169,67,55.2,122.3,2812910,None
Ponsegromab,Heart Valve Diseases,Heart Valve Diseases,0,0,0,0,0,61.6,60.6,122.2,1039957,None
Ponsegromab,Bladder/Urothelial Cancer,Bladder/Urothelial Cancer,0,0,0,0,0,65.6,56,121.6,264448,None
Ponsegromab,Neuromuscular Diseases,Neuromuscular Diseases,0,0,0,0,0,71.7,49.6,121.4,NA,None
Ponsegromab,Aortic Valve Stenosis,Aortic Valve Stenosis,0,0,0,0,0,62.8,58.2,121.1,81849,None
Ponsegromab,Chronic Heart Failure,Chronic Heart Failure,0,0,0,0,0,65.7,55.4,121.1,1823483,None
Ponsegromab,COVID-19 / SARS-CoV-2,COVID-19 / SARS-CoV-2,0,0,0,0,0,55.3,65.8,121.1,6689009,None
Ponsegromab,Early Stage,Early Stage,0,0,0,0,0,65.1,55.9,121,195041,None
Ponsegromab,Hypertension (High Blood Pressure),Hypertension (High Blood Pressure),0,0,0,0,0,77,44,121,NA,None
Ponsegromab,Geriatric Oncology,Geriatric Oncology,0,0,0,0,0,69,52,120.9,40818,None
Ponsegromab,Hyperglycemia,Hyperglycemia,0,0,0,0,0,61.6,58.4,120,2286884,None
Ponsegromab,Thromboembolism,Thromboembolism,0,0,0,0,0,54.4,65.6,120,2726821,None
Ponsegromab,Congenital Hemolytic Anemia,Congenital Hemolytic Anemia,0,0,0,0,0,66,53.3,119.3,NA,None
Ponsegromab,Hematologic Diseases (Hematology),Hematologic Diseases (Hematology),0,0,0,0,0,73.5,45.6,119.1,244323,None
Ponsegromab,Primary pulmonary hypertension,Pulmonary Hypertension,0.09,0,0.078845786,0.394228931,0.473074717,72.1,46.6,118.7,327,None
Ponsegromab,Metastatic Castration-Resistant Prostate Cancer (mCRPC),Metastatic Castration-Resistant Prostate Cancer (mCRPC),0,0,0,0,0,51,67.4,118.4,1754160,None
Ponsegromab,Bronchial Neoplasms,Bronchial Neoplasms,0,0,0,0,0,71.7,46.5,118.2,2121796,None
Ponsegromab,Aortic Valve Disease,Aortic Valve Disease,0,0,0,0,0,62.2,55.2,117.4,1422544,None
Ponsegromab,Hepatocellular Carcinoma (HCC),Hepatocellular Carcinoma (HCC),0,0,0,0,0,64.2,52.9,117.1,81849,None
Ponsegromab,Mitochondrial myopathy,Mitochondrial Myopathies,0,0,0.145903925,0.729172891,0.875076816,62.2,54.9,117.1,NA,None
Ponsegromab,Morbid Obesity,Morbid Obesity,0,0,0,0,0,57.8,59.3,117.1,2905055,None
Ponsegromab,Malnutrition,Malnutrition,0,0,0,0,0,65.2,51.7,116.9,17362891,None
Ponsegromab,Cerebral Small Vessel Diseases,Cerebral Small Vessel Diseases,0,0,0,0,0,52.4,64.4,116.8,3740328,None
Ponsegromab,Sepsis,Sepsis,0,0,0,0,0,68.2,48.4,116.6,247943,None
Ponsegromab,Benign Hematology,Benign Hematology,0,0,0,0,0,71,45.2,116.2,NA,None
Ponsegromab,Male Genital Neoplasms,Male Genital Neoplasms,0,0,0,0,0,73,43.2,116.2,2121796,None
Ponsegromab,Papillary Thyroid Cancer,Papillary Thyroid Cancer,0,0,0,0,0,54,61.9,115.9,2847695,None
Ponsegromab,Virus Diseases,Virus Diseases,0,0,0,0,0,69.6,46.2,115.8,1870094,None
Ponsegromab,Adiposity,Adiposity,0,0,0,0,0,58.5,57.1,115.6,1431863,None
Ponsegromab,Autoimmune Connective Tissue Diseases,Autoimmune Connective Tissue Diseases,0,0,0,0,0,68.6,47,115.6,16370,None
Ponsegromab,Castration Resistant Prostate Cancer (CRPC),Castration Resistant Prostate Cancer (CRPC),0,0,0,0,0,49.2,66.3,115.5,1754160,None
Ponsegromab,Liver Cancer,Liver Cancer,0,0,0,0,0,62.8,52.6,115.4,43154,None
Ponsegromab,Melanoma,Melanoma,0,0,0,0,0,71,44.3,115.4,NA,None
Ponsegromab,Pulmonary Fibrosis,Pulmonary Fibrosis,0,0,0,0,0,66.1,49.1,115.2,81849,None
Ponsegromab,Dyslipidemias,Dyslipidemias,0,0,0,0,0,54.5,60.5,115,71505530,None
Ponsegromab,Systemic Sclerosis (Scleroderma),Systemic Sclerosis (Scleroderma),0,0,0,0,0,60.2,54.8,115,81849,None
Ponsegromab,Atherosclerotic Cardiovascular Diseases (ASCVD),Atherosclerotic Cardiovascular Diseases (ASCVD),0,0,0,0,0,80.1,34.6,114.7,NA,None
Ponsegromab,End Stage Renal Disease (ESRD),End Stage Renal Disease (ESRD),0,0,0,0,0,62.9,51.8,114.7,560849,None
Ponsegromab,Peripheral Arterial Disease (PAD),Peripheral Arterial Disease (PAD),0,0,0,0,0,55.1,59.4,114.4,12439261,None
Ponsegromab,Kidney Failure,Kidney Failure,0.023465403,0.117327017,0.144467753,0.637313528,0.781781281,64.3,50.1,114.3,724456,None
Ponsegromab,Dilated Cardiomyopathy,Dilated Cardiomyopathy,0,0,0,0,0,57,57.2,114.2,81849,None
Ponsegromab,Gynecological Cancers,Gynecological Cancers,0,0,0,0,0,66.2,48,114.2,101693,None
Ponsegromab,Glucose Intolerance,Glucose Intolerance,0,0,0,0,0,59.7,54.2,113.9,2286884,None
Ponsegromab,Acid-Base Imbalance,Acid-Base Imbalance,0,0,0,0,0,56,57.8,113.8,5012635,None
Ponsegromab,Lipid Metabolism Disorders,Lipid Metabolism Disorders,0,0,0,0,0,58.2,55.5,113.8,45675932,None
Ponsegromab,Major Bleeding,Major Bleeding,0,0,0,0,0,67.5,46.3,113.8,141993,None
Ponsegromab,Embolism,Embolism,0,0,0,0,0,55.1,58.6,113.7,2726821,None
Ponsegromab,Prediabetes,Prediabetes,0,0,0,0,0,59.1,54.6,113.7,2286884,None
Ponsegromab,Metastatic Melanoma,Metastatic Melanoma,0,0,0,0,0,51,62.7,113.6,195041,None
Ponsegromab,Cognitive Impairment (Cognitive Dysfunction),Cognitive Impairment (Cognitive Dysfunction),0,0,0,0,0,59.1,54.2,113.3,1482060,None
Ponsegromab,Mitochondrial Encephalomyopathies,Mitochondrial Encephalomyopathies,0,0,0,0,0,51.5,61.9,113.3,269129,None
Ponsegromab,Fibrosis,Fibrosis,0,0,0,0,0,80.6,32.3,112.8,NA,None
Ponsegromab,Urination Disorders,Urination Disorders,0,0,0,0,0,66,46.6,112.7,11439598,None
Ponsegromab,Thalassemias,Thalassemias,0,0,0,0,0,67.1,45.4,112.5,7794,None
Ponsegromab,Venous Thromboembolisms (VTE),Venous Thromboembolisms (VTE),0,0,0,0,0,59.8,52.7,112.5,121167,None
Ponsegromab,Iron Deficiencies,Iron Deficiencies,0,0,0,0,0,56.9,55.3,112.2,14374961,None
Ponsegromab,Oral Cancer (Mouth Cancer),Oral Cancer (Mouth Cancer),0,0,0,0,0,55.8,56.2,112,170236,None
Ponsegromab,Acidosis,Acidosis,0,0,0,0,0,56.3,55.5,111.8,2888507,None
Ponsegromab,Arterial Occlusive Diseases,Arterial Occlusive Diseases,0,0,0,0,0,79.6,32.2,111.8,NA,None
Ponsegromab,Wasting Syndrome,Wasting Syndrome,0,0,0,0,0,54,57.8,111.8,NA,None
Ponsegromab,Peripheral Vascular Diseases,Peripheral Vascular Diseases,0,0,0,0,0,55.3,55.8,111.2,12439261,None
Ponsegromab,HFrEF,"Heart Failure with reduced Ejection Fraction (HFrEF, Systolic HF)",0.18,0,0.130460164,0.637324222,0.767784386,71,40,111,NA,None
Ponsegromab,Immune System Diseases,Immune System Diseases,0,0,0,0,0,70.9,40.1,111,NA,None
Ponsegromab,Interstitial Lung Diseases (ILD),Interstitial Lung Diseases (ILD),0,0,0,0,0,66.7,44.4,111,81849,None
Ponsegromab,Cardiac Fibrosis,Cardiac Fibrosis,0,0,0,0,0,73.8,36.9,110.7,NA,None
Ponsegromab,Pancreatic Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma,0,0,0,0,0,55.9,54.7,110.6,NA,None
Ponsegromab,Metastatic Breast Cancer,Metastatic Breast Cancer,0,0,0,0,0,42.9,67.1,110,4313770,None
Ponsegromab,Urinary Bladder Diseases,Urinary Bladder Diseases,0,0,0,0,0,64.7,45,109.8,1923031,None
Ponsegromab,Ovarian Cancer,Ovarian Cancer,0,0,0,0,0,68,41.6,109.7,101693,None
Ponsegromab,Neurodegenerative Diseases,Neurodegenerative Diseases,0,0,0,0,0,63,46.6,109.6,4893995,None
Ponsegromab,Anemia,Iron Deficiency Anemia,0.065238977,0.326194886,0.136913871,0.673064612,0.809978483,55.3,54.1,109.4,339369,None
Ponsegromab,Hypochromic Anemia,Hypochromic Anemia,0,0,0,0,0,55.3,54,109.3,339369,None
Ponsegromab,Head and Neck Squamous Cell Carcinoma (HNSCC),Head and Neck Squamous Cell Carcinoma (HNSCC),0,0,0,0,0,59.7,49.5,109.2,16370,None
Ponsegromab,Inborn Errors of Metabolism,Inborn Errors of Metabolism,0,0,0,0,0,63.7,45.5,109.2,45890,None
Ponsegromab,Iron Metabolism Disorders,Iron Metabolism Disorders,0,0,0,0,0,61.6,47.1,108.8,296860,None
Ponsegromab,Alcohol-Related Disorders,Alcohol-Related Disorders,0,0,0,0,0,57,51.7,108.7,440518,None
Ponsegromab,HIV,HIV,0,0,0,0,0,56.6,52,108.7,1740035,None
Ponsegromab,Upper Tract Urothelial Cancer (UTUC),Upper Tract Urothelial Cancer (UTUC),0,0,0,0,0,63.9,44.7,108.6,16370,None
Ponsegromab,Epithelial Ovarian Cancer,Epithelial Ovarian Cancer,0,0,0,0,0,48.3,59.9,108.2,101693,None
Ponsegromab,Urothelial Carcinoma (Transitional Cell Carcinoma),Urothelial Carcinoma (Transitional Cell Carcinoma),0,0,0,0,0,64.2,43.8,108.1,NA,None
Ponsegromab,Metabolic Syndrome,Metabolic Syndrome,0,0,0,0,0,59.2,48.5,107.7,45890,None
Ponsegromab,Pregnancy Complications,Pregnancy Complications,0,0,0,0,0,63.4,44.2,107.7,1253075,None
Ponsegromab,Acute Myeloid Leukemia (AML),Acute Myeloid Leukemia (AML),0,0,0,0,0,53.1,54.3,107.4,21332,None
Ponsegromab,Amyloidosis,Amyloidosis,0,0,0,0,0,50,57.2,107.2,16370,None
Ponsegromab,Left Ventricular Dysfunction,Left Ventricular Dysfunction,0,0,0,0,0,67.1,39.8,106.9,217128,None
Ponsegromab,Metabolic Dysfunction-Associated Steatohepatitis (MASH / NASH),Metabolic Dysfunction-Associated Steatohepatitis (MASH / NASH),0,0,0,0,0,58.8,48.1,106.9,NA,None
Ponsegromab,Ureteral Neoplasms,Ureteral Neoplasms,0,0,0,0,0,57.2,49.5,106.7,2121796,None
Ponsegromab,Lactic Acidosis,Lactic Acidosis,0,0,0,0,0,46.1,60.5,106.6,2888507,None
Ponsegromab,ST Elevation Myocardial Infarction,ST Elevation Myocardial Infarction,0,0,0,0,0,57.3,49.3,106.6,4844922,None
Ponsegromab,HER2 Positive (HER2+) Breast Cancer,HER2 Positive (HER2+) Breast Cancer,0,0,0,0,0,38.5,68,106.5,2277915,None
Ponsegromab,Esophageal Squamous Cell Carcinoma (ESCC),Esophageal Squamous Cell Carcinoma (ESCC),0,0,0,0,0,50,56.4,106.4,NA,None
Ponsegromab,Substance Use Disorders,Substance Use Disorders,0,0,0,0,0,55.3,51,106.4,10680870,None
Ponsegromab,Cardiovascular Abnormalities,Cardiovascular Abnormalities,0,0,0,0,0,57.5,48.6,106.2,2589546,None
Ponsegromab,Mental Disorders (Psychiatry),Mental Disorders (Psychiatry),0,0,0,0,0,63,43.1,106.1,1503512,None
Ponsegromab,Stomach Diseases,Stomach Diseases,0,0,0,0,0,58.3,47.8,106,2124128,None
Ponsegromab,Vascular Calcification,Vascular Calcification,0,0,0,0,0,51.2,54.8,106,577300,None
Ponsegromab,Inflammatory Diseases,Inflammatory Diseases,0,0,0,0,0,75.1,30.8,105.9,NA,None
Ponsegromab,Idiopathic Pulmonary Fibrosis (IPF),Idiopathic Pulmonary Fibrosis (IPF),0,0,0,0,0,56.5,49.2,105.7,81849,None
Ponsegromab,Metabolic Brain Diseases,Metabolic Brain Diseases,0,0,0,0,0,53.3,52.4,105.7,269129,None
Ponsegromab,Proteostasis Deficiencies,Proteostasis Deficiencies,0,0,0,0,0,52.5,53.2,105.7,NA,None
Ponsegromab,Heart Disease Risk Factors,Heart Disease Risk Factors,0,0,0,0,0,63.8,41.6,105.4,NA,None
Ponsegromab,Leukemias,Leukemias,0,0,0,0,0,51.2,54.2,105.4,218607,None
Ponsegromab,Respiration Disorders,Respiration Disorders,0,0,0,0,0,58.4,46.8,105.2,2449032,None
Ponsegromab,Idiopathic Interstitial Pneumonias (IIPs),Idiopathic Interstitial Pneumonias (IIPs),0,0,0,0,0,56.1,48.9,105.1,NA,None
Ponsegromab,Stomatognathic Diseases,Stomatognathic Diseases,0,0,0,0,0,67.9,37.2,105.1,3605239,None
Ponsegromab,Glioblastoma,Glioblastoma,0,0,0,0,0,56.6,48.4,104.9,16370,None
Ponsegromab,Adult Infectious Disease,Adult Infectious Disease,0,0,0,0,0,62,42.9,104.8,NA,None
Ponsegromab,Hormone-Sensitive Prostate Cancer (HSPC),Hormone-Sensitive Prostate Cancer (HSPC),0,0,0,0,0,42.1,62.8,104.8,1754160,None
Ponsegromab,Respiratory Distress Syndrome,Respiratory Distress Syndrome,0,0,0,0,0,54.5,50.3,104.8,NA,None
Ponsegromab,Iron Overload,Iron Overload,0,0,0,0,0,58,46.7,104.7,296860,None
Ponsegromab,Adenocarcinoma,Adenocarcinoma,0,0,0,0,0,72,32.5,104.5,NA,None
Ponsegromab,Atherosclerotic Plaque (Atherosclerosis),Atherosclerotic Plaque (Atherosclerosis),0,0,0,0,0,70,34.3,104.3,NA,None
Ponsegromab,IgA Nephropathy,IgA Nephropathy,0,0,0,0,0,46.7,57.1,103.8,1041348,None
Ponsegromab,Brain Ischemia,Brain Ischemia,0,0,0,0,0,51.7,52,103.7,269129,None
Ponsegromab,Gastric Cancer,Gastric Cancer,0,0,0,0,0,56.8,46.9,103.7,84947,None
Ponsegromab,Exocrine Pancreatic Cancer,Exocrine Pancreatic Cancer,0,0,0,0,0,56.2,47.4,103.6,NA,None
Ponsegromab,Hemolytic Anemia,Hemolytic Anemia,0,0,0,0,0,66.3,37.3,103.6,NA,None
Ponsegromab,Autoimmune Disorders,Autoimmune Disorders,0,0,0,0,0,72.3,31,103.3,NA,None
Ponsegromab,Infections (Infectious Diseases),Infections (Infectious Diseases),0,0,0,0,0,70.5,32.7,103.2,NA,None
Ponsegromab,Astrocytoma,Astrocytoma,0,0,0,0,0,56.8,46,102.8,16370,None
Ponsegromab,Thyroid Neoplasms,Thyroid Neoplasms,0,0,0,0,0,52.7,49.9,102.6,220320,None
Ponsegromab,Polyneuropathies,Polyneuropathies,0,0,0,0,0,45.7,56.8,102.5,3145758,None
Ponsegromab,Depressive Disorders / Depression,Depressive Disorders / Depression,0,0,0,0,0,49,53.4,102.4,15263323,None
Ponsegromab,Hemorrhagic Stroke,Hemorrhagic Stroke,0,0,0,0,0,40,62.4,102.4,7078728,None
Ponsegromab,Viral Hepatitis-Associated Hepatocellular Carcinoma,Viral Hepatitis-Associated Hepatocellular Carcinoma,0,0,0,0,0,60.9,41.5,102.4,NA,None
Ponsegromab,Congenital Abnormalities,Congenital Abnormalities,0,0,0,0,0,63.8,38.5,102.3,1482540,None
Ponsegromab,Mucositis,Mucositis,0,0,0,0,0,34.7,67.5,102.2,39214678,None
Ponsegromab,Cardiac Sudden Death,Cardiac Sudden Death,0,0,0,0,0,43.4,58.8,102.1,2921511,None
Ponsegromab,Acute Ischemic Stroke,Acute Ischemic Stroke,0,0,0,0,0,39.3,62.4,101.7,573257,None
Ponsegromab,Triple Negative Breast Cancer (TNBC),Triple Negative Breast Cancer (TNBC),0,0,0,0,0,35.1,66.6,101.7,2277915,None
Ponsegromab,Diabetic Cardiomyopathy,Diabetic Cardiomyopathy,0,0,0,0,0,42.9,58.6,101.5,25829598,None
Ponsegromab,Metastatic Colorectal Cancer (mCRC),Metastatic Colorectal Cancer (mCRC),0,0,0,0,0,45.9,55.6,101.5,NA,None
Ponsegromab,AIDS / HIV,AIDS / HIV,0,0,0,0,0,56.4,45,101.4,1740035,None
Ponsegromab,Sexually Transmitted Infections (STI),Sexually Transmitted Infections (STI),0,0,0,0,0,58.6,42.8,101.4,65151701,None
Ponsegromab,Myeloid Leukemia,Myeloid Leukemia,0,0,0,0,0,52.7,48.5,101.2,21332,None
Ponsegromab,Bone Metastases,Bone Metastases,0,0,0,0,0,49.9,50.6,100.4,NA,None
Ponsegromab,Cognition Disorders,Cognition Disorders,0,0,0,0,0,58.4,42,100.4,NA,None
Ponsegromab,Respiratory Tract Infections,Respiratory Tract Infections,0,0,0,0,0,53.7,46.7,100.4,299033,None
Ponsegromab,Congenital Heart Diseases,Congenital Heart Diseases,0,0,0,0,0,58.3,42.1,100.3,391835,None
Ponsegromab,Inborn Metabolic Brain Diseases,Inborn Metabolic Brain Diseases,0,0,0,0,0,53.8,46.4,100.2,342750,None
Ponsegromab,Thoracic Injuries,Thoracic Injuries,0,0,0,0,0,59.9,40.2,100.2,NA,None
Ponsegromab,Beta Thalassemia,Beta Thalassemia,0,0,0.129444517,0.647222587,0.776667104,50.5,49.2,99.8,16370,None
Ponsegromab,Acute Migraine,Acute Migraine,0,0,0,0,0,37.2,62.4,99.6,6166052,None
Ponsegromab,Dementia,Dementia,0,0,0,0,0,55.2,44.4,99.6,4893995,None
Ponsegromab,Acute Lung Injury,Acute Lung Injury,0,0,0,0,0,42.2,57.3,99.5,81849,None
Ponsegromab,Gliomas,Gliomas,0,0,0,0,0,54.9,44.5,99.5,NA,None
Ponsegromab,Embolic Stroke,Embolic Stroke,0,0,0,0,0,47,52.4,99.4,573257,None
Ponsegromab,Essential Hypertension,Essential Hypertension,0,0,0,0,0,41.4,58,99.4,61127270,None
Ponsegromab,Metastatic Lung Cancer,Metastatic Lung Cancer,0,0,0,0,0,44.3,55.1,99.4,NA,None
Ponsegromab,Water-Electrolyte Imbalance,Water-Electrolyte Imbalance,0,0,0,0,0,45.7,53.4,99.2,4206218,None
Ponsegromab,Localized Prostate Cancer,Localized Prostate Cancer,0,0,0,0,0,36.4,62.6,99,1754160,None
Ponsegromab,Connective Tissue Diseases,Connective Tissue Diseases,0,0,0,0,0,68.1,30.8,98.9,NA,None
Ponsegromab,Left Ventricular Hypertrophy,Left Ventricular Hypertrophy,0,0,0,0,0,53.1,45.7,98.9,2556982,None
Ponsegromab,Chronic Progressive Multiple Sclerosis,Chronic Progressive Multiple Sclerosis,0,0,0,0,0,36,62.7,98.8,791129,None
Ponsegromab,Diabetic Neuropathy,Diabetic Neuropathy,0,0,0,0,0,28.6,70.2,98.8,38789457,None
Ponsegromab,Advanced / Metastatic Breast Cancer,Advanced / Metastatic Breast Cancer,0,0,0,0,0,42.2,56.2,98.3,2277915,None
Ponsegromab,Critical Illness,Critical Illness,0,0,0,0,0,59.5,38.8,98.3,NA,None
Ponsegromab,Glomerulonephritis,Glomerulonephritis,0,0,0,0,0,55.6,42.7,98.3,783501,None
Ponsegromab,Cystadenocarcinoma,Cystadenocarcinoma,0,0,0,0,0,39.3,58.7,98,195041,None
Ponsegromab,Tauopathies,Tauopathies,0,0,0,0,0,53,45,98,4893995,None
Ponsegromab,Calcinosis,Calcinosis,0,0,0,0,0,47.9,50,97.9,296860,None
Ponsegromab,Plasma Cell Disorders,Plasma Cell Disorders,0,0,0,0,0,50.1,47.8,97.8,NA,None
Ponsegromab,Endometrial Cancer,Endometrial Cancer,0,0,0,0,0,45.7,51.8,97.5,NA,None
Ponsegromab,Leukoencephalopathies,Leukoencephalopathies,0,0,0,0,0,39.1,58.4,97.5,2040622,None
Ponsegromab,Mitochondrial DNA Depletion Syndromes (MDDS),Mitochondrial DNA Depletion Syndromes (MDDS),0,0,0,0,0,59.3,38.2,97.5,NA,None
Ponsegromab,Paraproteinemias,Paraproteinemias,0,0,0,0,0,49.7,47.5,97.1,NA,None
Ponsegromab,Occupational Asthma,Occupational Asthma,0,0,0,0,0,40.5,56.5,97,18578193,None
Ponsegromab,Polycystic Ovary Syndrome (PCOS),Polycystic Ovary Syndrome (PCOS),0,0,0,0,0,43.6,53.4,97,4819447,None
Ponsegromab,Primary Progressive Multiple Sclerosis (PPMS),Primary Progressive Multiple Sclerosis (PPMS),0,0,0,0,0,37.6,59.2,96.8,791129,None
Ponsegromab,Parkinson's Disease,Parkinson's Disease,0,0,0,0,0,49.2,47.5,96.7,617093,None
Ponsegromab,Osteoarthritis,Osteoarthritis,0,0,0,0,0,40.5,56.1,96.5,51773846,None
Ponsegromab,Anaplastic Thyroid Cancer,Anaplastic Thyroid Cancer,0,0,0,0,0,41.7,54.7,96.4,1637,None
Ponsegromab,Hepatitis C / HCV,Hepatitis C / HCV,0,0,0,0,0,45.1,51.3,96.4,19931,None
Ponsegromab,Radiation Injuries,Radiation Injuries,0,0,0,0,0,58.2,38.1,96.4,NA,None
Ponsegromab,Bone Neoplasms,Bone Neoplasms,0,0,0,0,0,46.6,49.7,96.3,2121796,None
Ponsegromab,Hyperlipidemias,Hyperlipidemias,0,0,0,0,0,40.9,55.4,96.3,45675932,None
Ponsegromab,Lung Adenocarcinoma,Lung Adenocarcinoma,0,0,0,0,0,34.3,62,96.3,689620,None
Ponsegromab,Nervous System Tumors,Nervous System Tumors,0,0,0,0,0,55.2,41.1,96.3,NA,None
Ponsegromab,Alzheimer's Disease,Alzheimer's Disease,0,0,0,0,0,53.1,43.1,96.2,4893995,None
Ponsegromab,Pediatric Respiratory Diseases,Pediatric Respiratory Diseases,0,0,0,0,0,47.7,48.5,96.1,2449032,None
Ponsegromab,Motor Neuron Disease,Motor Neuron Disease,0,0,0,0,0,43.6,52.4,96,37666,None
Ponsegromab,Thrombosis,Thrombosis,0,0,0,0,0,53.2,42.7,95.9,121167,None
Ponsegromab,Acute Pain,Acute Pain,0,0,0,0,0,50.7,45.1,95.8,4258038,None
Ponsegromab,Chronic Migraine,Chronic Migraine,0,0,0,0,0,39.8,55.9,95.7,6166052,None
Ponsegromab,Leigh Disease,Leigh Disease,0,0,0,0,0,44.3,51.4,95.7,16370,None
Ponsegromab,Ovarian Cysts,Ovarian Cysts,0,0,0,0,0,43.2,52.5,95.7,789207,None
Ponsegromab,Pulmonary Embolism (PE),Pulmonary Embolism (PE),0,0,0,0,0,47,48.4,95.4,400457,None
Ponsegromab,MELAS Syndrome,MELAS Syndrome,0,0,0,0,0,50.9,44.4,95.3,1637,None
Ponsegromab,Amyotrophic lateral sclerosis,Amyotrophic Lateral Sclerosis (ALS),0.02418989,0.120949449,0.156898725,0.639862641,0.796761366,43.8,51.4,95.2,16370,None
Ponsegromab,Reperfusion Injury,Reperfusion Injury,0,0,0,0,0,53.6,41.6,95.1,NA,None
Ponsegromab,Synucleinopathies,Synucleinopathies,0,0,0,0,0,48.9,46,94.9,307912,None
Ponsegromab,Vision Disorders,Vision Disorders,0,0,0,0,0,43.2,51.7,94.9,10701413,None
Ponsegromab,Breast Ductal Carcinoma,Breast Ductal Carcinoma,0,0,0,0,0,36.6,57.9,94.5,2277915,None
Ponsegromab,Mouth Diseases,Mouth Diseases,0,0,0,0,0,65,29.5,94.5,429740,None
Ponsegromab,Avitaminosis,Avitaminosis,0,0,0,0,0,47.3,47.1,94.4,4616527,None
Ponsegromab,Lower-Risk Myelodysplastic Syndromes (MDS),Lower-Risk Myelodysplastic Syndromes (MDS),0,0,0,0,0,40.4,54,94.4,NA,None
Ponsegromab,Right Ventricular Dysfunction,Right Ventricular Dysfunction,0,0,0,0,0,49.7,44.7,94.4,1823483,None
Ponsegromab,Adult Sickle Cell Disease,Adult Sickle Cell Disease,0,0,0,0,0,40.7,53.5,94.2,NA,None
Ponsegromab,Hereditary Sensory and Motor Neuropathy,Hereditary Sensory and Motor Neuropathy,0,0,0,0,0,46.6,47.7,94.2,NA,None
Ponsegromab,High-Risk Prostate Cancer,High-Risk Prostate Cancer,0,0,0,0,0,36.6,57.3,93.8,1754160,None
Ponsegromab,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathies,0,0,0,0,0,48,45.7,93.7,327,None
Ponsegromab,Rheumatoid Arthritis (RA),Rheumatoid Arthritis (RA),0,0,0,0,0,43.8,49.8,93.7,1619893,None
Ponsegromab,Charcot-Marie-Tooth Disease,Charcot-Marie-Tooth Disease,0,0,0,0,0,47.4,46.1,93.5,NA,None
Ponsegromab,Pancreatic Intraductal Neoplasms,Pancreatic Intraductal Neoplasms,0,0,0,0,0,42.8,50.6,93.4,3659822,None
Ponsegromab,Head and Neck Cancers,Head and Neck Cancers,0,0,0,0,0,48.9,44.4,93.3,40818,None
Ponsegromab,Nervous System Heredodegenerative Disorders,Nervous System Heredodegenerative Disorders,0,0,0,0,0,46.4,46.9,93.3,1499787,None
Ponsegromab,TDP-43 Proteinopathies,TDP-43 Proteinopathies,0,0,0,0,0,43,50.3,93.3,NA,None
Ponsegromab,Central Nervous System Tumors,Central Nervous System Tumors,0,0,0,0,0,52.1,41.2,93.2,NA,None
Ponsegromab,Pancreatitis,Pancreatitis,0,0,0,0,0,51.5,41.7,93.2,264485,None
Ponsegromab,Rheumatic Diseases (Rheumatology),Rheumatic Diseases (Rheumatology),0,0,0,0,0,49.7,43.5,93.2,10763146,None
Ponsegromab,Non-Promyelocytic Acute Myeloid Leukemia (Non-M3 AML),Non-Promyelocytic Acute Myeloid Leukemia (Non-M3 AML),0,0,0,0,0,53.5,39.6,93.1,NA,None
Ponsegromab,Small Cell Lung Cancer (SCLC),Small Cell Lung Cancer (SCLC),0,0,0,0,0,33.7,59.2,92.9,689620,None
Ponsegromab,Pediatric Thalassemias,Pediatric Thalassemias,0,0,0,0,0,48,44.8,92.8,NA,None
Ponsegromab,Asthma,Asthma,0,0,0,0,0,38.9,53.7,92.5,33894211,None
Ponsegromab,Cancer-Associated Thrombosis,Cancer-Associated Thrombosis,0,0,0,0,0,35.9,56.6,92.4,121167,None
Ponsegromab,Open-Angle Glaucoma,Open-Angle Glaucoma,0,0,0,0,0,54,38.4,92.4,5025903,None
Ponsegromab,Severe Aortic Valve Insufficiency,Severe Aortic Valve Insufficiency,0,0,0,0,0,46.7,45.7,92.4,75729,None
Ponsegromab,Alcoholic Liver Disease,Alcoholic Liver Disease,0,0,0,0,0,36.7,55.7,92.3,NA,None
Ponsegromab,Eye Diseases (Ophthalmology),Eye Diseases (Ophthalmology),0,0,0,0,0,54.7,37.6,92.3,2351767,None
Ponsegromab,Parkinsonian Disorders,Parkinsonian Disorders,0,0,0,0,0,48.1,44.1,92.2,696404,None
Ponsegromab,Uterine Neoplasms,Uterine Neoplasms,0,0,0,0,0,52.8,39.3,92.1,629407,None
Ponsegromab,Disease Susceptibility,Disease Susceptibility,0,0,0,0,0,53.4,38.5,91.9,NA,None
Ponsegromab,Childhood Leukemia,Childhood Leukemia,0,0,0,0,0,31.2,60.6,91.8,687573,None
Ponsegromab,Papillary Adenocarcinoma,Papillary Adenocarcinoma,0,0,0,0,0,53.8,38,91.8,NA,None
Ponsegromab,Liver Metastases,Liver Metastases,0,0,0,0,0,35.6,55.9,91.6,195041,None
Ponsegromab,Generalized Epilepsy,Generalized Epilepsy,0,0,0,0,0,47.3,44.1,91.4,1242619,None
Ponsegromab,Nephritis,Nephritis,0.024762563,0,0.133691814,0.60654384,0.740235654,54.3,36.9,91.2,NA,None
Ponsegromab,Non-Valvular Atrial Fibrillation (NVAF),Non-Valvular Atrial Fibrillation (NVAF),0,0,0,0,0,39.4,51.8,91.2,3881520,None
Ponsegromab,Alpha Thalassemia,Alpha Thalassemia,0,0,0,0,0,53.2,38,91.1,81849,None
Ponsegromab,Bipolar Disorders,Bipolar Disorders,0,0,0,0,0,42.6,48.5,91,2118350,None
Ponsegromab,Colonic Neoplasms,Colonic Neoplasms,0,0,0,0,0,48.3,42.6,91,2121796,None
Ponsegromab,Systemic Lupus Erythematosus (SLE),Systemic Lupus Erythematosus (SLE),0,0,0,0,0,50.5,40.6,91,81849,None
Ponsegromab,Gestational Diabetes,Gestational Diabetes,0,0,0,0,0,52.3,38.3,90.7,379951,None
Ponsegromab,Kidney Cancer,Kidney Cancer,0,0,0,0,0,48.6,42.1,90.7,364034,None
Ponsegromab,Aneurysm,Aneurysm,0,0,0,0,0,42.1,48.5,90.6,157386,None
Ponsegromab,Chronic Kidney Disease (CKD) and Atherosclerotic Cardiovascular Disease (ASCVD),Chronic Kidney Disease (CKD) and Atherosclerotic Cardiovascular Disease (ASCVD),0,0,0,0,0,50.2,40.3,90.5,NA,None
Ponsegromab,Migraine,Migraine,0,0,0,0,0,37.2,53.3,90.5,56636035,None
Ponsegromab,Hereditary Eye Diseases,Hereditary Eye Diseases,0,0,0,0,0,41.1,49.2,90.3,4984643,None
Ponsegromab,HIV Infections,HIV Infections,0,0,0,0,0,53,37.3,90.2,NA,None
Ponsegromab,Viral Hepatitis,Viral Hepatitis,0,0,0,0,0,48.9,41.3,90.2,225712,None
Ponsegromab,Cardio-Pulmonary Complications in Sickle Cell Disease (SCD),Cardio-Pulmonary Complications in Sickle Cell Disease (SCD),0,0,0,0,0,37.7,52.2,89.9,400457,None
Ponsegromab,Primary Headache Disorders,Primary Headache Disorders,0,0,0,0,0,36.8,52.9,89.7,140063157,None
Ponsegromab,Invasive Ductal Carcinoma (IDC),Invasive Ductal Carcinoma (IDC),0,0,0,0,0,35.5,54.2,89.6,2277915,None
Ponsegromab,Focal Segmental Glomerulosclerosis (FSGS),Focal Segmental Glomerulosclerosis (FSGS),0,0,0,0,0,39.1,50.4,89.5,NA,None
Ponsegromab,Thymidine Kinase 2 Deficiency (TK2D),Thymidine Kinase 2 Deficiency (TK2D),0,0,0,0,0,52.6,36.9,89.5,45890,None
Ponsegromab,Type 1 Diabetes Mellitus,Type 1 Diabetes Mellitus,0,0,0,0,0,45.9,43.6,89.4,2654918,None
Ponsegromab,Chronic Hepatitis,Chronic Hepatitis,0,0,0,0,0,51.9,37.3,89.2,NA,None
Ponsegromab,Ureteral Obstruction,Ureteral Obstruction,0,0,0,0,0,41.8,47.4,89.2,2439938,None
Ponsegromab,Esophageal Cancer,Esophageal Cancer,0,0,0,0,0,48.3,40.8,89.1,40475,None
Ponsegromab,Hepatitis,Hepatitis,0,0,0,0,0,49.9,39.2,89.1,315864,None
Ponsegromab,Immunologic Deficiency Syndromes,Immunologic Deficiency Syndromes,0,0,0,0,0,54.4,34.7,89.1,NA,None
Ponsegromab,Multiple Myeloma,Multiple Myeloma,0,0,0,0,0,42.9,46.1,89,89407,None
Ponsegromab,Endometrial Carcinoma,Endometrial Carcinoma,0,0,0,0,0,40.6,48.3,88.9,NA,None
Ponsegromab,Gram-Negative Bacterial Infections,Gram-Negative Bacterial Infections,0,0,0,0,0,41.2,47.5,88.7,1944266,None
Ponsegromab,Sexually Transmitted Viral Diseases,Sexually Transmitted Viral Diseases,0,0,0,0,0,51.8,36.9,88.7,NA,None
Ponsegromab,Chronic Pancreatitis,Chronic Pancreatitis,0,0,0,0,0,41.4,47,88.5,1637,None
Ponsegromab,Platinum-Sensitive Ovarian Cancer,Platinum-Sensitive Ovarian Cancer,0,0,0,0,0,37.2,51.3,88.5,101693,None
Ponsegromab,Comorbidities in Psoriasis,Comorbidities in Psoriasis,0,0,0,0,0,33.1,55.4,88.4,1550095,None
Ponsegromab,Platinum-Resistant/Refractory Ovarian Cancer,Platinum-Resistant/Refractory Ovarian Cancer,0,0,0,0,0,36.7,51.7,88.4,101693,None
Ponsegromab,Bronchopulmonary Dysplasia,Bronchopulmonary Dysplasia,0,0,0,0,0,45,43.3,88.3,81849,None
Ponsegromab,Myeloid Neoplasms,Myeloid Neoplasms,0,0,0,0,0,53.7,34.6,88.3,NA,None
Ponsegromab,Chemotherapy-Induced Nausea and Vomiting (CINV),Chemotherapy-Induced Nausea and Vomiting (CINV),0,0,0,0,0,54.9,33.4,88.2,NA,None
Ponsegromab,Myeloproliferative Neoplasms (MPN) (excl. CML),Myeloproliferative Neoplasms (MPN) (excl. CML),0,0,0,0,0,41.2,47.1,88.2,16370,None
Ponsegromab,Inborn Errors of Lipid Metabolism,Inborn Errors of Lipid Metabolism,0,0,0,0,0,34.1,54,88.1,45675932,None
Ponsegromab,Cardio-Renal Syndrome,Cardio-Renal Syndrome,0.18,0,0.116911356,0.584556782,0.701468138,35.1,52.9,88,3198905,None
Ponsegromab,Metastatic Pancreatic Cancer,Metastatic Pancreatic Cancer,0,0,0,0,0,29.3,58.7,88,1530938,None
Ponsegromab,Primary Myelofibrosis (PMF),Primary Myelofibrosis (PMF),0,0,0,0,0,40.9,47.2,88,16370,None
Ponsegromab,Myositis,Myositis,0,0,0,0,0,46.8,41.1,87.9,NA,None
Ponsegromab,Vascular Dementia,Vascular Dementia,0,0,0,0,0,37.6,50.3,87.9,NA,None
Ponsegromab,Aortic Diseases,Aortic Diseases,0,0,0,0,0,44.1,43.7,87.8,150024,None
Ponsegromab,Headache Disorders,Headache Disorders,0,0,0,0,0,36.5,51.3,87.8,140063157,None
Ponsegromab,Tooth Loss,Tooth Loss,0,0,0,0,0,43.8,44,87.7,7830354,None
Ponsegromab,Chemical and Drug Induced Liver Injury,Chemical and Drug Induced Liver Injury,0,0,0,0,0,40.9,46.7,87.6,662991,None
Ponsegromab,Anemia in Chronic Kidney Disease (CKD),Anemia in Chronic Kidney Disease (CKD),0,0,0,0,0,36.3,51.2,87.5,40170198,None
Ponsegromab,Basal Ganglia Diseases,Basal Ganglia Diseases,0,0,0,0,0,48.9,38.6,87.5,269129,None
Ponsegromab,Heart Failure with Mid-Range Ejection Fraction (HFmEF),Heart Failure with Mid-Range Ejection Fraction (HFmEF),0,0,0,0,0,51.6,35.9,87.5,NA,None
Ponsegromab,Membranous Nephropathy,Membranous Nephropathy,0,0,0,0,0,48.4,39,87.5,NA,None
Ponsegromab,Advanced/Metastatic Liver Cancer,Advanced/Metastatic Liver Cancer,0,0,0,0,0,41.8,45.5,87.4,47927,None
Ponsegromab,Angina Pectoris,Angina Pectoris,0,0,0,0,0,42.6,44.9,87.4,1655376,None
Ponsegromab,Cutaneous Melanoma,Cutaneous Melanoma,0,0,0,0,0,49.1,38.3,87.4,NA,None
Ponsegromab,Bone Resorption,Bone Resorption,0,0,0,0,0,49.1,38.3,87.3,654874,None
Ponsegromab,Liver Failure,Liver Failure,0,0,0,0,0,40.9,46.4,87.3,NA,None
Ponsegromab,Pseudomonas Infections,Pseudomonas Infections,0,0,0,0,0,31.8,55.4,87.2,1944266,None
Ponsegromab,Hepatic Insufficiency,Hepatic Insufficiency,0,0,0,0,0,40.8,46.3,87.1,NA,None
Ponsegromab,Hypothyroidism,Hypothyroidism,0,0,0,0,0,43.2,43.7,87,9886949,None
Ponsegromab,Myelodysplastic Syndromes (MDS),Myelodysplastic Syndromes (MDS),0,0,0,0,0,40,47,87,16370,None
Ponsegromab,RET Positive Thyroid Cancer,RET Positive Thyroid Cancer,0,0,0,0,0,30.1,56.9,87,220320,None
Ponsegromab,Amyloid Light-Chain (AL) Amyloidosis,Amyloid Light-Chain (AL) Amyloidosis,0,0,0,0,0,33.4,53.5,86.9,16370,None
Ponsegromab,Ductal Carcinoma In Situ (DCIS),Ductal Carcinoma In Situ (DCIS),0,0,0,0,0,32.5,54.4,86.9,2277915,None
Ponsegromab,Choline Deficiency,Choline Deficiency,0,0,0,0,0,48.3,38.6,86.8,901348,None
Ponsegromab,Inborn Errors of Pyruvate Metabolism,Inborn Errors of Pyruvate Metabolism,0,0,0,0,0,45.5,41.2,86.7,NA,None
Ponsegromab,Intracranial Hemorrhage,Intracranial Hemorrhage,0,0,0,0,0,40,46.7,86.7,662592,None
Ponsegromab,Cardiorespiratory Failure,Cardiorespiratory Failure,0,0,0,0,0,34.3,52.3,86.6,1539079,None
Ponsegromab,Low-Risk Prostate Cancer,Low-Risk Prostate Cancer,0,0,0,0,0,35.4,51.1,86.6,1754160,None
Ponsegromab,Progressive Pulmonary Fibrosis,Progressive Pulmonary Fibrosis,0,0,0,0,0,37.1,49.4,86.6,NA,None
Ponsegromab,Uterine Sarcoma,Uterine Sarcoma,0,0,0,0,0,36.6,49.9,86.5,116613,None
Ponsegromab,Bloodstream Infections,Bloodstream Infections,0,0,0,0,0,42.7,43.7,86.4,247943,None
Ponsegromab,Diabetic Angiopathies,Diabetic Angiopathies,0,0,0,0,0,28.9,57.4,86.4,25829598,None
Ponsegromab,MSI-High/MMR-Deficient Cancers,MSI-High/MMR-Deficient Cancers,0,0,0,0,0,28.8,57.6,86.4,195041,None
Ponsegromab,Pediatric Oncology,Pediatric Oncology,0,0,0,0,0,44.9,41.3,86.3,NA,None
Ponsegromab,Periodontal Diseases,Periodontal Diseases,0,0,0,0,0,45.9,40.4,86.3,42074382,None
Ponsegromab,Tooth Diseases,Tooth Diseases,0,0,0,0,0,50.1,36.2,86.3,3387914,None
Ponsegromab,Blood Protein Disorders,Blood Protein Disorders,0,0,0,0,0,41.9,44.3,86.2,NA,None
Ponsegromab,Endometrioid Carcinoma,Endometrioid Carcinoma,0,0,0,0,0,36.9,49.4,86.2,101693,None
Ponsegromab,Movement Disorders,Movement Disorders,0,0,0,0,0,48.1,38,86.2,1894974,None
Ponsegromab,Renal Pelvis Cancer,Renal Pelvis Cancer,0,0,0,0,0,51.7,34.5,86.2,NA,None
Ponsegromab,Brain Neoplasms,Brain Neoplasms,0,0,0,0,0,47.5,38.6,86.1,2121796,None
Ponsegromab,Chronic Hepatitis B,Chronic Hepatitis B,0,0,0,0,0,46.3,39.7,86.1,NA,None
Ponsegromab,Sickle Cell Disease (SCD),Sickle Cell Disease (SCD),0,0,0,0,0,37.6,48.3,86,38397,None
Ponsegromab,Muscular Dystrophies,Muscular Dystrophies,0,0,0,0,0,36.7,49.3,85.9,NA,None
Ponsegromab,Refractory Anemia,Refractory Anemia,0,0,0,0,0,37.5,48.3,85.8,327,None
Ponsegromab,Inflammatory Bowel Diseases (IBD),Inflammatory Bowel Diseases (IBD),0,0,0,0,0,41.8,43.9,85.7,761536,None
Ponsegromab,Thrombocytopenia,Thrombocytopenia,0,0,0,0,0,46.6,39.1,85.7,NA,None
Ponsegromab,Atrophic Muscular Disorders,Atrophic Muscular Disorders,0,0,0,0,0,36.5,49.2,85.6,NA,None
Ponsegromab,Heart Arrest,Heart Arrest,0,0,0,0,0,37.9,47.7,85.6,NA,None
Ponsegromab,Inclusion Body Myositis,Inclusion Body Myositis,0,0,0,0,0,43.4,42.2,85.6,1637,None
Ponsegromab,Sensation Disorders,Sensation Disorders,0,0,0,0,0,45.5,40.1,85.6,419363,None
Ponsegromab,Benign Prostatic Hyperplasia (BPH),Benign Prostatic Hyperplasia (BPH),0,0,0,0,0,44.5,40.9,85.4,4618278,None
Ponsegromab,Hypotension,Hypotension,0,0,0,0,0,43.1,42.2,85.3,307912,None
Ponsegromab,Osteoporosis,Osteoporosis,0,0,0,0,0,45.9,39.3,85.3,2062944,None
Ponsegromab,Chronic Limb-Threatening Ischemia (CLTI) (Critical Limb Ischemia (CLI)),Chronic Limb-Threatening Ischemia (CLTI) (Critical Limb Ischemia (CLI)),0,0,0,0,0,40.7,44.5,85.1,35157,None
Ponsegromab,Metabolically Benign Obesity,Metabolically Benign Obesity,0,0,0,0,0,35.5,49.6,85.1,1431863,None
Ponsegromab,Deficiency Diseases,Deficiency Diseases,0,0,0,0,0,47.2,37.7,84.9,NA,None
Ponsegromab,Infectious Pneumonia (excl. COVID-19/SARS-COV-2),Infectious Pneumonia (excl. COVID-19/SARS-COV-2),0,0,0,0,0,23.2,61.7,84.9,3889803,None
Ponsegromab,Intrahepatic Cholestasis,Intrahepatic Cholestasis,0,0,0,0,0,34.8,50,84.8,190066,None
Ponsegromab,Hepatitis B / HBV,Hepatitis B / HBV,0,0,0,0,0,46.9,37.8,84.7,24457,None
Ponsegromab,Pediatric/Adolescent Acute Lymphoblastic Leukemia (ALL),Pediatric/Adolescent Acute Lymphoblastic Leukemia (ALL),0,0,0,0,0,34.2,50.6,84.7,NA,None
Ponsegromab,Chronic Fatigue Syndrome,Chronic Fatigue Syndrome,0,0,0,0,0,32.9,51.6,84.5,1674290,None
Ponsegromab,Dermatitis,Dermatitis,0,0,0,0,0,38,46.5,84.5,16554753,None
Ponsegromab,Acute-On-Chronic Liver Failure,Acute-On-Chronic Liver Failure,0,0,0,0,0,34.7,49.7,84.4,NA,None
Ponsegromab,Spinal Diseases,Spinal Diseases,0,0,0,0,0,44.1,40.3,84.4,1042505,None
Ponsegromab,Metabolic Bone Diseases,Metabolic Bone Diseases,0,0,0,0,0,45.6,38.6,84.2,45890,None
Ponsegromab,Rhinovirus,Rhinovirus,0,0,0,0,0,44.2,39.9,84.1,NA,None
Ponsegromab,Arthritis,Arthritis,0,0,0,0,0,53.9,30.1,84,NA,None
Ponsegromab,Calcium Metabolism Disorders,Calcium Metabolism Disorders,0,0,0,0,0,45.4,38.6,84,296860,None
Ponsegromab,Lupus Nephritis,Lupus Nephritis,0,0,0,0,0,31.7,52.1,83.8,614364,None
Ponsegromab,Pediatric Migraine,Pediatric Migraine,0,0,0,0,0,31.2,52.6,83.8,6166052,None
Ponsegromab,Peripheral Primitive Neuroectodermal Tumors,Peripheral Primitive Neuroectodermal Tumors,0,0,0,0,0,32,51.7,83.7,327,None
Ponsegromab,Capsule Opacification,Capsule Opacification,0,0,0,0,0,36.3,47.3,83.6,6419666,None
Ponsegromab,Brain Infarction,Brain Infarction,0,0,0,0,0,28.6,54.9,83.5,573257,None
Ponsegromab,Seizures,Seizures,0,0,0,0,0,44.2,39.3,83.5,1749202,None
Ponsegromab,Venous Thrombosis,Venous Thrombosis,0,0,0,0,0,41.6,41.9,83.5,121167,None
Ponsegromab,Acute Liver Failure,Acute Liver Failure,0,0,0,0,0,33.9,49.5,83.4,81849,None
Ponsegromab,Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI),Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI),0,0,0,0,0,46.8,36.6,83.4,NA,None
Ponsegromab,Ventilator-Induced Lung Injury,Ventilator-Induced Lung Injury,0,0,0,0,0,44.9,38.5,83.4,NA,None
Ponsegromab,Chronic Hepatitis C,Chronic Hepatitis C,0,0,0,0,0,37.4,45.9,83.3,19931,None
Ponsegromab,Organ Damage in Sickle Cell Disease (SCD),Organ Damage in Sickle Cell Disease (SCD),0,0,0,0,0,34.3,49,83.3,NA,None
Ponsegromab,Uveal Melanoma,Uveal Melanoma,0,0,0,0,0,34.4,48.8,83.3,16370,None
Ponsegromab,Cervical Cancer,Cervical Cancer,0,0,0,0,0,35.7,47.5,83.2,110262,None
Ponsegromab,Metastatic Hormone-Sensitive Prostate Cancer (mHSPC),Metastatic Hormone-Sensitive Prostate Cancer (mHSPC),0,0,0,0,0,42.6,40.6,83.2,NA,None
Ponsegromab,Relapsed/Refractory AML,Relapsed/Refractory AML,0,0,0,0,0,35.8,47.4,83.2,NA,None
Ponsegromab,Dedifferentiated Liposarcoma (DDLPS),Dedifferentiated Liposarcoma (DDLPS),0,0,0,0,0,30.6,52.5,83.1,1637,None
Ponsegromab,Epilepsy,Epilepsy,0,0,0,0,0,38.8,44.3,83.1,1088244,None
Ponsegromab,Coronary Microvascular Disease (CMD),Coronary Microvascular Disease (CMD),0,0,0,0,0,23.5,59.5,83,8139256,None
Ponsegromab,Crohn's Disease,Crohn's Disease,0,0,0,0,0,36.3,46.7,83,553856,None
Ponsegromab,Metastatic NSCLC,Metastatic NSCLC,0,0,0,0,0,33.1,49.9,83,NA,None
Ponsegromab,Pediatric Major Depressive Disorder (MDD),Pediatric Major Depressive Disorder (MDD),0,0,0,0,0,24.9,58,83,21367254,None
Ponsegromab,Abdominal Obesity,Abdominal Obesity,0,0,0,0,0,26.4,56.6,82.9,1431863,None
Ponsegromab,Glaucoma,Glaucoma,0,0,0,0,0,50.7,32.3,82.9,263334,None
Ponsegromab,Soft Tissue Sarcomas,Soft Tissue Sarcomas,0,0,0,0,0,37.5,45.4,82.9,81849,None
Ponsegromab,Spinal Muscular Atrophy (SMA),Spinal Muscular Atrophy (SMA),0,0,0,0,0,33.9,49,82.9,NA,None
Ponsegromab,Fibrosarcoma,Fibrosarcoma,0,0,0,0,0,32.7,50.1,82.8,327,None
Ponsegromab,Follicular Thyroid Cancer,Follicular Thyroid Cancer,0,0,0,0,0,33.1,49.7,82.8,220320,None
Ponsegromab,Long Covid,Long Covid,0,0,0,0,0,41.2,41.5,82.7,NA,None
Ponsegromab,Consciousness Disorders,Consciousness Disorders,0,0,0,0,0,36.4,46.2,82.6,2156800,None
Ponsegromab,RET Positive NSCLC,RET Positive NSCLC,0,0,0,0,0,29.4,53.2,82.6,689620,None
Ponsegromab,Bipolar Depression,Bipolar Depression,0,0,0,0,0,43.9,38.6,82.5,2710150,None
Ponsegromab,Eczematous Skin Diseases,Eczematous Skin Diseases,0,0,0,0,0,33,49.4,82.4,92111522,None
Ponsegromab,Gastritis,Gastritis,0,0,0,0,0,36.4,45.8,82.3,950045,None
Ponsegromab,Univentricular Heart,Univentricular Heart,0,0,0,0,0,43.3,38.8,82.1,16370,None
Ponsegromab,Anorexia Nervosa,Anorexia Nervosa,0,0,0.125983384,0.629916922,0.755900306,29.8,52.3,82,369845,None
Ponsegromab,Locally Advanced Prostate Cancer,Locally Advanced Prostate Cancer,0,0,0,0,0,24.7,57.2,82,1754160,None
Ponsegromab,Retinal Diseases,Retinal Diseases,0,0,0,0,0,45.4,36.6,82,2767515,None
Ponsegromab,Urinary Calculi,Urinary Calculi,0,0,0,0,0,38.4,43.6,82,NA,None
Ponsegromab,Fractures,Fractures,0,0,0,0,0,45.9,36,81.9,1368518,None
Ponsegromab,Thyroid Cancer,Thyroid Cancer,0,0,0,0,0,52.9,28.8,81.8,NA,None
Ponsegromab,Inborn Errors of Carbohydrate Metabolism,Inborn Errors of Carbohydrate Metabolism,0,0,0,0,0,39.6,42.1,81.7,NA,None
Ponsegromab,Right Ventricular Hypertrophy,Right Ventricular Hypertrophy,0,0,0,0,0,35.9,45.8,81.7,2556982,None
Ponsegromab,Viremia,Viremia,0,0,0,0,0,28.9,52.8,81.7,1870094,None
Ponsegromab,Spinal Cord Diseases,Spinal Cord Diseases,0,0,0,0,0,43.5,38.1,81.6,NA,None
Ponsegromab,Hypertrophic Cardiomyopathy (HCM),Hypertrophic Cardiomyopathy (HCM),0,0,0,0,0,32.6,48.9,81.5,41382,None
Ponsegromab,Gram-Positive Bacterial Infections,Gram-Positive Bacterial Infections,0,0,0,0,0,30.3,51.2,81.4,1944266,None
Ponsegromab,Pediatric Kidney Diseases (Pediatric Nephrology),Pediatric Kidney Diseases (Pediatric Nephrology),0,0,0,0,0,41.4,40,81.4,NA,None
Ponsegromab,Proteinuria,Proteinuria,0,0,0,0,0,54.4,27,81.4,NA,None
Ponsegromab,Acute Pancreatitis,Acute Pancreatitis,0,0,0,0,0,27.5,53.8,81.3,195577,None
Ponsegromab,Vascular System Injuries,Vascular System Injuries,0,0,0,0,0,41.2,40.1,81.3,4384071,None
Ponsegromab,Brain Injuries,Brain Injuries,0,0,0,0,0,37.3,43.9,81.2,1069335,None
Ponsegromab,Protein Deficiency,Protein Deficiency,0,0,0,0,0,39.4,41.8,81.2,NA,None
Ponsegromab,Lipodystrophy,Lipodystrophy,0,0,0,0,0,44.5,36.6,81.1,45890,None
Ponsegromab,Experimental Neoplasms,Experimental Neoplasms,0,0,0,0,0,40.7,40.2,81,2121796,None
Ponsegromab,Hearing Disorders,Hearing Disorders,0,0,0,0,0,32.4,48.6,81,4167114,None
Ponsegromab,Higher-Risk Myelodysplastic Syndromes (MDS),Higher-Risk Myelodysplastic Syndromes (MDS),0,0,0,0,0,36.8,44.3,81,NA,None
Ponsegromab,Spondylitis,Spondylitis,0,0,0,0,0,46.7,34,80.8,207320,None
Ponsegromab,Cardiogenic Shock,Cardiogenic Shock,0,0,0,0,0,34.2,46.6,80.7,81849,None
Ponsegromab,Hydronephrosis,Hydronephrosis,0,0,0,0,0,47,33.7,80.7,NA,None
Ponsegromab,Lung Injury,Lung Injury,0,0,0,0,0,47.8,32.8,80.6,81849,None
Ponsegromab,Cerebral Hemorrhage,Cerebral Hemorrhage,0,0,0,0,0,32.8,47.7,80.5,NA,None
Ponsegromab,Growth Deficiency,Growth Deficiency,0,0,0,0,0,41.8,38.6,80.4,NA,None
Ponsegromab,Host vs Graft Reaction,Host vs Graft Reaction,0,0,0,0,0,46.4,34,80.4,NA,None
Ponsegromab,Sarcomas,Sarcomas,0,0,0,0,0,36.8,43.6,80.4,NA,None
Ponsegromab,Influenza,Influenza,0,0,0,0,0,29.8,50.5,80.3,51477657,None
Ponsegromab,Ptosis,Ptosis,0,0,0,0,0,40.7,39.6,80.3,419363,None
Ponsegromab,Hereditary Ataxias,Hereditary Ataxias,0,0,0,0,0,41,39.2,80.2,NA,None
Ponsegromab,Lewy Body Disease,Lewy Body Disease,0,0,0,0,0,30.4,49.7,80.1,NA,None
Ponsegromab,Chest Pain,Chest Pain,0,0,0,0,0,43.7,36.2,80,2734085,None
Ponsegromab,Hemorrhagic Disorders,Hemorrhagic Disorders,0,0,0,0,0,41.9,38,80,NA,None
Ponsegromab,Psoriasis,Psoriasis,0,0,0,0,0,37,43,80,4224396,None
Ponsegromab,Respiratory Syncytial Virus Infections,Respiratory Syncytial Virus Infections,0,0,0,0,0,27.4,52.4,79.9,7646849,None
Ponsegromab,Cerebral Infarction,Cerebral Infarction,0,0,0,0,0,25,54.6,79.7,573257,None
Ponsegromab,POLG-Related Disorders,POLG-Related Disorders,0,0,0,0,0,36,43.7,79.7,NA,None
Ponsegromab,Autistic Disorder,Autistic Disorder,0,0,0,0,0,30.8,48.8,79.6,52877846,None
Ponsegromab,Intracranial Arteriosclerosis,Intracranial Arteriosclerosis,0,0,0,0,0,36.1,43.3,79.5,NA,None
Ponsegromab,Ophthalmoplegia,Ophthalmoplegia,0,0,0,0,0,41,38.5,79.5,NA,None
Ponsegromab,Biliary Tract Cancers (Biliary Tumors),Biliary Tract Cancers (Biliary Tumors),0,0,0,0,0,32.7,46.6,79.3,NA,None
Ponsegromab,Refractory Epilepsy,Refractory Epilepsy,0,0,0,0,0,21.5,57.8,79.3,1242619,None
Ponsegromab,Preeclampsia,Preeclampsia,0,0,0,0,0,48.1,31.1,79.2,379951,None
Ponsegromab,Headaches,Headaches,0,0,0,0,0,33.2,45.9,79.1,140063157,None
Ponsegromab,Liposarcoma,Liposarcoma,0,0,0,0,0,26.4,52.7,79.1,1637,None
Ponsegromab,Multiple Sclerosis (MS),Multiple Sclerosis (MS),0,0,0,0,0,33,46.1,79.1,408491,None
Ponsegromab,Nervous System Trauma,Nervous System Trauma,0,0,0,0,0,43.2,35.8,79.1,4384071,None
Ponsegromab,Blood Platelet Disorders,Blood Platelet Disorders,0,0,0,0,0,46.3,32.7,79,NA,None
Ponsegromab,CNS Demyelinating Autoimmune Diseases,CNS Demyelinating Autoimmune Diseases,0,0,0,0,0,33.1,45.7,78.8,791129,None
Ponsegromab,Congenital Dyserythropoietic Anemia,Congenital Dyserythropoietic Anemia,0,0,0,0,0,42.9,35.9,78.8,1637,None
Ponsegromab,Spontaneous Abortion,Spontaneous Abortion,0,0,0,0,0,36.4,42.2,78.7,266019,None
Ponsegromab,Rectal Cancer,Rectal Cancer,0,0,0,0,0,33.6,45,78.6,1374344,None
Ponsegromab,Tonic-Clonic Seizures,Tonic-Clonic Seizures,0,0,0,0,0,45.1,33.5,78.6,1242619,None
Ponsegromab,Feeding and Eating Disorders,Feeding and Eating Disorders,0,0,0,0,0,39.9,38.6,78.5,1239081,None
Ponsegromab,Hyperemesis Gravidarum,Hyperemesis Gravidarum,0,0,0.177803393,0.682322127,0.86012552,52.9,25.5,78.5,NA,None
Ponsegromab,Locally Advanced Gastric Cancer,Locally Advanced Gastric Cancer,0,0,0,0,0,26.1,52.3,78.4,NA,None
Ponsegromab,Myosarcoma,Myosarcoma,0,0,0,0,0,30.4,48,78.4,NA,None
Ponsegromab,Rhabdomyosarcoma,Rhabdomyosarcoma,0,0,0,0,0,30.4,48,78.4,1637,None
Ponsegromab,Benign Gastrointestinal Tumors,Benign Gastrointestinal Tumors,0,0,0,0,0,46.3,32,78.3,NA,None
Ponsegromab,Inborn Errors of Steroid Metabolism,Inborn Errors of Steroid Metabolism,0,0,0,0,0,40.1,37.9,78.1,45675932,None
Ponsegromab,Ganglion Cysts,Ganglion Cysts,0,0,0,0,0,46.8,31.2,78,259932,None
Ponsegromab,Non-Transfusion Dependent Adult Thalassemias,Non-Transfusion Dependent Adult Thalassemias,0,0,0,0,0,42.7,35.3,78,NA,None
Ponsegromab,Peripheral Nervous System Diseases (Peripheral Neuropathy),Peripheral Nervous System Diseases (Peripheral Neuropathy),0,0,0,0,0,52.5,25.6,78,NA,None
Ponsegromab,Transfusion Dependency,Transfusion Dependency,0,0,0,0,0,42.1,35.8,77.9,NA,None
Ponsegromab,Compensated Cirrhosis,Compensated Cirrhosis,0,0,0,0,0,24.7,53.1,77.8,190066,None
Ponsegromab,Gout,Gout,0,0,0,0,0,36,41.7,77.7,8640207,None
Ponsegromab,Non-ST Elevated Myocardial Infarction,Non-ST Elevated Myocardial Infarction,0,0,0,0,0,28.8,49,77.7,4844922,None
Ponsegromab,Pediatric Asthma,Pediatric Asthma,0,0,0,0,0,14.1,63.6,77.7,18578193,None
Ponsegromab,Spinal Tuberculosis,Spinal Tuberculosis,0,0,0,0,0,30,47.7,77.7,36821459,None
Ponsegromab,Uterine Fibroids,Uterine Fibroids,0,0,0,0,0,35.2,42.2,77.4,11652039,None
Ponsegromab,Diabetic Eye Disease,Diabetic Eye Disease,0,0,0,0,0,24.9,52.3,77.2,25829598,None
Ponsegromab,Hypertriglyceridemia,Hypertriglyceridemia,0,0,0,0,0,36.2,41,77.2,45675932,None
Ponsegromab,Familial Amyloidosis,Familial Amyloidosis,0,0,0,0,0,31.7,45.4,77.1,NA,None
Ponsegromab,Inborn Errors of Amino Acid Metabolism,Inborn Errors of Amino Acid Metabolism,0,0,0,0,0,47.6,29.4,77.1,NA,None
Ponsegromab,Toxemia,Toxemia,0,0,0,0,0,35.7,41.3,77,247943,None
Ponsegromab,Adrenal Gland Diseases,Adrenal Gland Diseases,0,0,0,0,0,44.9,31.9,76.8,NA,None
Ponsegromab,Pulmonary Emphysema,Pulmonary Emphysema,0,0,0,0,0,25.6,51.2,76.8,1611127,None
Ponsegromab,Urolithiasis,Urolithiasis,0,0,0,0,0,37.1,39.7,76.8,159610,None
Ponsegromab,Bacterial Infections,Bacterial Infections,0,0,0,0,0,49.5,27.2,76.7,NA,None
Ponsegromab,Neuroinflammatory Diseases,Neuroinflammatory Diseases,0,0,0,0,0,37.5,39.2,76.7,NA,None
Ponsegromab,Muscle Tissue Neoplasms,Muscle Tissue Neoplasms,0,0,0,0,0,36,40.6,76.6,222015,None
Ponsegromab,Adrenal Insufficiency,Adrenal Insufficiency,0,0,0,0,0,39.5,37.1,76.5,327,None
Ponsegromab,Extensive Disease Small Cell Lung Cancer (SCLC),Extensive Disease Small Cell Lung Cancer (SCLC),0,0,0,0,0,39.4,37,76.5,NA,None
Ponsegromab,Huntington Disease,Huntington Disease,0,0,0,0,0,30.5,45.9,76.5,16370,None
Ponsegromab,Encephalomyelitis,Encephalomyelitis,0,0,0,0,0,30.8,45.6,76.4,1637,None
Ponsegromab,Metastatic Gastric Cancer,Metastatic Gastric Cancer,0,0,0,0,0,29.2,47.2,76.4,NA,None
Ponsegromab,Vitamin B Deficiency,Vitamin B Deficiency,0,0,0,0,0,47.1,29.2,76.4,901348,None
Ponsegromab,Hormone-Dependent Neoplasms,Hormone-Dependent Neoplasms,0,0,0,0,0,41.6,34.7,76.3,2121796,None
Ponsegromab,Spinal Cord Injury (SCI),Spinal Cord Injury (SCI),0,0,0,0,0,38.7,37.5,76.2,81849,None
Ponsegromab,Abdominal Aortic Aneurysm,Abdominal Aortic Aneurysm,0,0,0,0,0,28.8,47.3,76.1,255560,None
Ponsegromab,Coronary Stenosis,Coronary Stenosis,0,0,0,0,0,29.8,46.3,76.1,8139256,None
Ponsegromab,Gallbladder Cancer,Gallbladder Cancer,0,0,0,0,0,25.5,50.5,76.1,18356,None
Ponsegromab,Beta Thalassemia Major,Beta Thalassemia Major,0,0,0,0,0,30.8,45.1,75.9,327397,None
Ponsegromab,Dry Age-Related Macular Degeneration (Dry AMD),Dry Age-Related Macular Degeneration (Dry AMD),0,0,0,0,0,29.6,46.3,75.9,2767515,None
Ponsegromab,Low Back Pain,Low Back Pain,0,0,0,0,0,17,59,75.9,52012960,None
Ponsegromab,Osteonecrosis,Osteonecrosis,0,0,0,0,0,38.7,37.1,75.9,NA,None
Ponsegromab,Metabolic Skin Diseases,Metabolic Skin Diseases,0,0,0,0,0,44.3,31.5,75.8,45890,None
Ponsegromab,Acquired Immunodeficiency Syndrome,Acquired Immunodeficiency Syndrome,0,0,0,0,0,37.5,38.1,75.6,NA,None
Ponsegromab,Aplastic Anemia,Aplastic Anemia,0,0,0,0,0,37.3,38.3,75.6,1637,None
Ponsegromab,Down Syndrome,Down Syndrome,0,0,0,0,0,34.6,40.9,75.5,101114,None
Ponsegromab,Sleep Apnea,Sleep Apnea,0,0,0,0,0,20.9,54.6,75.5,15439078,None
Ponsegromab,Leiomyoma,Leiomyoma,0,0,0,0,0,36.8,38.5,75.4,327,None
Ponsegromab,Retinal Degeneration,Retinal Degeneration,0,0,0,0,0,32.2,43.2,75.4,81849,None
Ponsegromab,Hypertensive Disorders of Pregnancy,Hypertensive Disorders of Pregnancy,0,0,0,0,0,46.9,28.3,75.3,111875,None
Ponsegromab,Tricuspid Valve Diseases,Tricuspid Valve Diseases,0,0,0,0,0,40.1,35.2,75.3,NA,None
Ponsegromab,Wernicke Encephalopathy,Wernicke Encephalopathy,0,0,0,0,0,37.2,38.1,75.3,NA,None
Ponsegromab,Gaucher Disease,Gaucher Disease,0,0,0,0,0,33.8,41.4,75.2,1637,None
Ponsegromab,Hydrops Fetalis,Hydrops Fetalis,0,0,0,0,0,40.3,34.8,75.2,327397,None
Ponsegromab,Acute Monocytic Leukemia,Acute Monocytic Leukemia,0,0,0,0,0,31.5,43.6,75.1,NA,None
Ponsegromab,Cytopenia,Cytopenia,0,0,0,0,0,46.3,28.9,75.1,NA,None
Ponsegromab,Muscle Invasive Bladder/Urothelial Cancer (MIBC),Muscle Invasive Bladder/Urothelial Cancer (MIBC),0,0,0,0,0,13.3,61.7,75,264229,None
Ponsegromab,Non-Melanoma Skin Cancers (NMSC),Non-Melanoma Skin Cancers (NMSC),0,0,0,0,0,26.6,48.2,74.8,2040603,None
Ponsegromab,Nervous System Lysosomal Storage Diseases,Nervous System Lysosomal Storage Diseases,0,0,0,0,0,34.6,40.1,74.7,NA,None
Ponsegromab,HER2 Negative (HER2-) Breast Cancer,HER2 Negative (HER2-) Breast Cancer,0,0,0,0,0,32.8,41.8,74.6,NA,None
Ponsegromab,Myelofibrosis,Myelofibrosis,0,0,0,0,0,35.9,38.7,74.6,16370,None
Ponsegromab,Obstructive Sleep Apnea,Obstructive Sleep Apnea,0,0,0,0,0,21.1,53.5,74.6,15439078,None
Ponsegromab,Experimental Mammary Neoplasms,Experimental Mammary Neoplasms,0,0,0,0,0,23.1,51.4,74.5,2277915,None
Ponsegromab,Neuroblastoma,Neuroblastoma,0,0,0,0,0,32.1,42.4,74.5,81849,None
Ponsegromab,Neurological Autoimmune Diseases (Neuroimmunology),Neurological Autoimmune Diseases (Neuroimmunology),0,0,0,0,0,43.3,31.2,74.5,NA,None
Ponsegromab,Amyloid Neuropathies,Amyloid Neuropathies,0,0,0,0,0,31.3,43.2,74.4,NA,None
Ponsegromab,Endotoxemia,Endotoxemia,0,0,0,0,0,37.2,37.2,74.4,108560,None
Ponsegromab,Fabry Disease,Fabry Disease,0,0,0,0,0,29.7,44.7,74.4,1637,None
Ponsegromab,Gallbladder Diseases,Gallbladder Diseases,0,0,0,0,0,28.1,46.2,74.3,9990482,None
Ponsegromab,Gastric Adenocarcinoma,Gastric Adenocarcinoma,0,0,0,0,0,34.8,39.4,74.2,NA,None
Ponsegromab,Familial Amyloid Neuropathies,Familial Amyloid Neuropathies,0,0,0,0,0,30.8,43.3,74.1,NA,None
Ponsegromab,Schizophrenia Spectrum and Other Psychotic Disorders,Schizophrenia Spectrum and Other Psychotic Disorders,0,0,0,0,0,34.2,39.9,74.1,3760276,None
Ponsegromab,Sleep Wake Disorders,Sleep Wake Disorders,0,0,0,0,0,28.5,45.6,74.1,21155274,None
Ponsegromab,Trauma and Stressor Related Disorders,Trauma and Stressor Related Disorders,0,0,0,0,0,25.5,48.6,74.1,5115302,None
Ponsegromab,Biliary Tract Diseases,Biliary Tract Diseases,0,0,0,0,0,38.1,35.8,73.9,NA,None
Ponsegromab,Granulomatosis with Polyangiitis,Granulomatosis with Polyangiitis,0,0,0,0,0,32.6,41.3,73.9,1637,None
Ponsegromab,Chronic Rhinosinusitis without Nasal Polyps (CRSsNP),Chronic Rhinosinusitis without Nasal Polyps (CRSsNP),0,0,0,0,0,26.8,46.8,73.5,8216633,None
Ponsegromab,Cytokine Release Syndrome,Cytokine Release Syndrome,0,0,0,0,0,26.2,47.2,73.4,NA,None
Ponsegromab,Connective Tissue Neoplasms,Connective Tissue Neoplasms,0,0,0,0,0,35.5,37.8,73.3,2121796,None
Ponsegromab,Degenerative Disc Disease,Degenerative Disc Disease,0,0,0,0,0,24.8,48.5,73.3,3949644,None
Ponsegromab,Fungal Infections,Fungal Infections,0,0,0,0,0,28.4,44.9,73.3,10559423,None
Ponsegromab,Transthyretin Amyloidosis (ATTR),Transthyretin Amyloidosis (ATTR),0,0,0.102411275,0.512056373,0.614467648,28.5,44.8,73.3,NA,None
Ponsegromab,Hip Fractures,Hip Fractures,0,0,0,0,0,34.3,38.9,73.2,411883,None
Ponsegromab,Neuroendocrine Carcinomas,Neuroendocrine Carcinomas,0,0,0,0,0,36.7,36.5,73.2,NA,None
Ponsegromab,Polymyositis,Polymyositis,0,0,0,0,0,38.2,35,73.2,16370,None
Ponsegromab,Subarachnoid Hemorrhage (SAH),Subarachnoid Hemorrhage (SAH),0,0,0,0,0,19.9,53.2,73.1,848226,None
Ponsegromab,Acute Lymphoblastic Leukemia (ALL),Acute Lymphoblastic Leukemia (ALL),0,0,0,0,0,32.6,40.5,73,13653,None
Ponsegromab,Addison Disease,Addison Disease,0,0,0,0,0,37.8,34.9,72.7,81849,None
Ponsegromab,Intrinsic Sleep Disorders,Intrinsic Sleep Disorders,0,0,0,0,0,29.2,43.5,72.7,17503252,None
Ponsegromab,Subvalvular Aortic Stenosis,Subvalvular Aortic Stenosis,0,0,0,0,0,32.6,40.2,72.7,NA,None
Ponsegromab,Non-Muscle Invasive Bladder/Urothelial Cancer (NMIBC),Non-Muscle Invasive Bladder/Urothelial Cancer (NMIBC),0,0,0,0,0,36,36.6,72.6,NA,None
Ponsegromab,Medulloblastoma,Medulloblastoma,0,0,0,0,0,27.4,45.1,72.5,16370,None
Ponsegromab,Diffuse Scleroderma,Diffuse Scleroderma,0,0,0,0,0,22.3,50.1,72.4,NA,None
Ponsegromab,Respiratory Syncytial Virus (RSV),Respiratory Syncytial Virus (RSV),0,0,0,0,0,25.9,46.5,72.4,94607,None
Ponsegromab,Systemic Vasculitis,Systemic Vasculitis,0,0,0,0,0,29.2,43.2,72.4,150024,None
Ponsegromab,Nervous System Malformations,Nervous System Malformations,0,0,0,0,0,42.1,30.2,72.3,NA,None
Ponsegromab,Out-of-Hospital Cardiac Arrest,Out-of-Hospital Cardiac Arrest,0,0,0,0,0,23.6,48.7,72.3,NA,None
Ponsegromab,Sideroblastic Anemia,Sideroblastic Anemia,0,0,0,0,0,36.6,35.7,72.3,327,None
Ponsegromab,Aortic Aneurysm,Aortic Aneurysm,0,0,0,0,0,25.5,46.6,72.2,0,None
Ponsegromab,Lower Respiratory Tract Infections (LRTI),Lower Respiratory Tract Infections (LRTI),0,0,0,0,0,45,27,72.1,NA,None
Ponsegromab,Lymphoid Leukemia,Lymphoid Leukemia,0,0,0,0,0,33.1,39,72.1,NA,None
Ponsegromab,Hyperlactatemia,Hyperlactatemia,0,0,0,0,0,19.9,52.1,72,2888507,None
Ponsegromab,Papilloma,Papilloma,0,0,0,0,0,36.8,35.2,72,41995,None
Ponsegromab,Post-Traumatic Stress Disorder (PTSD),Post-Traumatic Stress Disorder (PTSD),0,0,0,0,0,25.7,46.3,72,5115302,None
Ponsegromab,Spondyloarthritis,Spondyloarthritis,0,0,0,0,0,38.7,33.3,72,16370,None
Ponsegromab,Agranulocytosis,Agranulocytosis,0,0,0,0,0,32.7,39.2,71.9,NA,None
Ponsegromab,Autism Spectrum Disorder (ASD),Autism Spectrum Disorder (ASD),0,0,0,0,0,30.8,41.2,71.9,1975452,None
Ponsegromab,Femoral Fractures,Femoral Fractures,0,0,0,0,0,33.6,38.2,71.8,411883,None
Ponsegromab,Traumatic Stress Disorders,Traumatic Stress Disorders,0,0,0,0,0,25.6,46.2,71.8,5115302,None
Ponsegromab,Exfoliation Syndrome,Exfoliation Syndrome,0,0,0,0,0,31.3,40.4,71.7,5025903,None
Ponsegromab,Experimental Diabetes Mellitus,Experimental Diabetes Mellitus,0,0,0,0,0,30.6,41.1,71.7,NA,None
Ponsegromab,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,0,0,0,0,0,30.3,41.3,71.6,81849,None
Ponsegromab,Testicular Tumor,Testicular Tumor,0,0,0,0,0,42.2,29.4,71.6,111779,None
Ponsegromab,Deep Vein Thrombosis (DVT),Deep Vein Thrombosis (DVT),0,0,0,0,0,36,35.5,71.5,121167,None
Ponsegromab,Hyperuricemia,Hyperuricemia,0,0,0,0,0,39.6,31.9,71.5,NA,None
Ponsegromab,TP53 mutated Hepatocellular Carcinoma,TP53 mutated Hepatocellular Carcinoma,0,0,0,0,0,44.1,27.2,71.3,NA,None
Ponsegromab,Diarrhea,Diarrhea,0,0,0,0,0,31.8,39.4,71.2,2469834,None
Ponsegromab,Macular Degeneration,Macular Degeneration,0,0,0,0,0,30.7,40.5,71.2,2767515,None
Ponsegromab,Hematuria,Hematuria,0,0,0,0,0,45.8,25.3,71.1,449535,None
Ponsegromab,Leukopenia,Leukopenia,0,0,0,0,0,35.7,35.4,71.1,32564,None
Ponsegromab,Muscle Neoplasms,Muscle Neoplasms,0,0,0,0,0,35.8,35.2,71.1,2121796,None
Ponsegromab,Ventricular Fibrillation,Ventricular Fibrillation,0,0,0,0,0,28.4,42.8,71.1,2921511,None
Ponsegromab,Newborn Respiratory Distress Syndrome,Newborn Respiratory Distress Syndrome,0,0,0,0,0,23.8,47.2,71,NA,None
Ponsegromab,Pneumonia,Pneumonia,0,0,0,0,0,22.4,48.6,71,3889803,None
Ponsegromab,Pseudotumor Cerebri,Pseudotumor Cerebri,0,0,0,0,0,33.5,37.4,71,269129,None
Ponsegromab,Rupture,Rupture,0,0,0,0,0,44.4,26.6,71,NA,None
Ponsegromab,Cholestasis,Cholestasis,0,0,0,0,0,31.4,39.4,70.8,NA,None
Ponsegromab,Hyperkalemia,Hyperkalemia,0,0,0,0,0,21.5,49.3,70.8,2888507,None
Ponsegromab,Albuminuria,Albuminuria,0,0,0,0,0,34.1,36.7,70.7,NA,None
Ponsegromab,Obesity Hypoventilation Syndrome,Obesity Hypoventilation Syndrome,0,0,0,0,0,23.9,46.8,70.7,1431863,None
Ponsegromab,Retinal Dystrophies,Retinal Dystrophies,0,0,0,0,0,24.7,46,70.7,2767515,None
Ponsegromab,Vascular Skin Diseases,Vascular Skin Diseases,0,0,0,0,0,31.5,39.1,70.7,581299,None
Ponsegromab,Chronic Myelomonocytic Leukemia (CMML),Chronic Myelomonocytic Leukemia (CMML),0,0,0,0,0,37.3,33.2,70.6,1637,None
Ponsegromab,Deaf-Blind Disorders,Deaf-Blind Disorders,0,0,0,0,0,29.9,40.7,70.6,283157,None
Ponsegromab,Digital Ulcer,Digital Ulcer,0,0,0,0,0,17,53.5,70.6,4549237,None
Ponsegromab,Stable Angina,Stable Angina,0,0,0,0,0,31.2,39.4,70.6,1655376,None
Ponsegromab,Craniocerebral Trauma,Craniocerebral Trauma,0,0,0,0,0,35.6,35,70.5,934529,None
Ponsegromab,Psychological Trauma,Psychological Trauma,0,0,0,0,0,24.3,46.1,70.4,5115302,None
Ponsegromab,Vasculitis,Vasculitis,0,0,0,0,0,32.4,38,70.4,16370,None
Ponsegromab,Hyperthyroidism,Hyperthyroidism,0,0,0,0,0,33.2,37.1,70.3,1493062,None
Ponsegromab,KRAS mutated Exocrine Pancreatic Cancer,KRAS mutated Exocrine Pancreatic Cancer,0,0,0,0,0,35.1,35.2,70.3,NA,None
Ponsegromab,Adipose Tissue Neoplasms,Adipose Tissue Neoplasms,0,0,0,0,0,24.5,45.7,70.2,2312219,None
Ponsegromab,Secondary Headache Disorders,Secondary Headache Disorders,0,0,0,0,0,28.5,41.7,70.2,172367,None
Ponsegromab,Clear Cell Adenocarcinoma,Clear Cell Adenocarcinoma,0,0,0,0,0,33,37.1,70.1,NA,None
Ponsegromab,Fibrous Tissue Neoplasms,Fibrous Tissue Neoplasms,0,0,0,0,0,33.2,36.9,70.1,1152512,None
Ponsegromab,Intellectual Disability,Intellectual Disability,0,0,0,0,0,35.2,34.9,70.1,1314313,None
Ponsegromab,Vitamin D Deficiency,Vitamin D Deficiency,0,0,0,0,0,29.5,40.5,70,3461624,None
Ponsegromab,Vascular Malformations,Vascular Malformations,0,0,0,0,0,25,45,69.9,726773,None
Ponsegromab,Diabetic Ketoacidosis,Diabetic Ketoacidosis,0,0,0,0,0,26.9,42.7,69.7,25829598,None
Ponsegromab,Helicobacter Infections,Helicobacter Infections,0,0,0,0,0,15.1,54.6,69.7,1944266,None
Ponsegromab,Ocular Motility Disorders,Ocular Motility Disorders,0,0,0,0,0,36.7,33,69.7,NA,None
Ponsegromab,Inherited Retinal Diseases (IRD),Inherited Retinal Diseases (IRD),0,0,0,0,0,24.5,45.1,69.6,2767515,None
Ponsegromab,Autoimmune Hepatitis,Autoimmune Hepatitis,0,0,0,0,0,11.3,58.2,69.5,81849,None
Ponsegromab,Nodular Goiter,Nodular Goiter,0,0,0,0,0,30.8,38.7,69.5,864685,None
Ponsegromab,Estrogen-Receptor Positive (ER+) Breast Cancer,Estrogen-Receptor Positive (ER+) Breast Cancer,0,0,0,0,0,30.5,38.8,69.3,NA,None
Ponsegromab,Infectious Bone Diseases,Infectious Bone Diseases,0,0,0,0,0,28.5,40.8,69.3,207320,None
Ponsegromab,Non-Squamous NSCLC,Non-Squamous NSCLC,0,0,0,0,0,14.3,54.9,69.2,689620,None
Ponsegromab,Alagille Syndrome,Alagille Syndrome,0,0,0,0,0,32,37,69.1,16370,None
Ponsegromab,Histiocytosis,Histiocytosis,0,0,0,0,0,24.9,44.2,69.1,475630,None
Ponsegromab,Knee Osteoarthritis,Knee Osteoarthritis,0,0,0,0,0,26.4,42.7,69.1,1072300,None
Ponsegromab,Nasal Polyps,Nasal Polyps,0,0,0,0,0,35.8,33.3,69.1,NA,None
Ponsegromab,Preterm Birth,Preterm Birth,0,0,0,0,0,35.4,33.7,69.1,3946100,None
Ponsegromab,Nephrosis,Nephrosis,0,0,0,0,0,27.7,41.3,69,7143053,None
Ponsegromab,Soft Tissue Neoplasms,Soft Tissue Neoplasms,0,0,0,0,0,29.4,39.6,69,2121796,None
Ponsegromab,Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD),Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD),0,0,0,0,0,30.7,38.2,68.9,NA,None
Ponsegromab,Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (CTD-PAH),Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (CTD-PAH),0,0,0,0,0,44.2,24.7,68.9,NA,None
Ponsegromab,Eye Tumors,Eye Tumors,0,0,0,0,0,32,36.9,68.9,2121796,None
Ponsegromab,Metastatic Triple Negative Breast Cancer (mTNBC),Metastatic Triple Negative Breast Cancer (mTNBC),0,0,0,0,0,28.5,40.4,68.9,NA,None
Ponsegromab,Periodontitis,Periodontitis,0,0,0,0,0,35.2,33.7,68.9,358292,None
Ponsegromab,Acne Vulgaris,Acne Vulgaris,0,0,0,0,0,32.5,36.4,68.8,8550527,None
Ponsegromab,Gestational Trophoblastic Disease,Gestational Trophoblastic Disease,0,0,0,0,0,36.3,32.5,68.7,327,None
Ponsegromab,Hereditary Transthyretin Amyloidosis (hATTR),Hereditary Transthyretin Amyloidosis (hATTR),0,0,0,0,0,31.9,36.9,68.7,1637,None
Ponsegromab,Precancerous Conditions,Precancerous Conditions,0,0,0,0,0,37.5,31.2,68.7,NA,None
Ponsegromab,Pulmonary Hypertension Due to Left Heart Disease,Pulmonary Hypertension Due to Left Heart Disease,0,0,0,0,0,36.7,32,68.7,NA,None
Ponsegromab,Cataract,Cataract,0,0,0,0,0,31.6,37,68.6,1702138,None
Ponsegromab,Teratoma,Teratoma,0,0,0,0,0,21.8,46.8,68.6,493475,None
Ponsegromab,Difficult Asthma,Difficult Asthma,0,0,0,0,0,10.2,58.3,68.5,18578193,None
Ponsegromab,Invasive Hydatidiform Mole,Invasive Hydatidiform Mole,0,0,0,0,0,41.9,26.6,68.5,NA,None
Ponsegromab,Respiratory Insufficiency,Respiratory Insufficiency,0,0,0,0,0,21.1,47.2,68.4,3181185,None
Ponsegromab,Vascular Tissue Neoplasms,Vascular Tissue Neoplasms,0,0,0,0,0,26.4,42,68.4,NA,None
Ponsegromab,Atrial Septal Defects (Heart),Atrial Septal Defects (Heart),0,0,0,0,0,31.2,37,68.3,NA,None
Ponsegromab,Dwarfism,Dwarfism,0,0,0,0,0,27.6,40.7,68.3,1427302,None
Ponsegromab,EGFR mutated NSCLC,EGFR mutated NSCLC,0,0,0,0,0,10.4,57.9,68.3,689620,None
Ponsegromab,Mitral Valve Diseases,Mitral Valve Diseases,0,0,0,0,0,24.1,44.2,68.3,473541,None
Ponsegromab,Lipidoses,Lipidoses,0,0,0,0,0,35.4,32.8,68.2,NA,None
Ponsegromab,Newly Diagnosed Glioblastoma,Newly Diagnosed Glioblastoma,0,0,0,0,0,31.9,36.3,68.2,NA,None
Ponsegromab,Retinitis Pigmentosa,Retinitis Pigmentosa,0,0,0,0,0,26.6,41.6,68.2,81849,None
Ponsegromab,Trichostrongyloidiasis,Trichostrongyloidiasis,0,0,0,0,0,42.1,26.2,68.2,NA,None
Ponsegromab,Diabetic Foot,Diabetic Foot,0,0,0,0,0,18.8,49.3,68.1,25869925,None
Ponsegromab,Carotid Stenosis,Carotid Stenosis,0,0,0,0,0,33.8,34.2,68,77460,None
Ponsegromab,Pandemics,Pandemics,0,0,0,0,0,33,35.1,68,NA,None
Ponsegromab,Salivary Gland Diseases,Salivary Gland Diseases,0,0,0,0,0,28.9,39.1,68,47843,None
Ponsegromab,Epidemics,Epidemics,0,0,0,0,0,32.8,35,67.9,NA,None
Ponsegromab,Primary Dysautonomias,Primary Dysautonomias,0,0,0,0,0,19.5,48.4,67.9,81849,None
Ponsegromab,Breast Carcinoma In Situ,Breast Carcinoma In Situ,0,0,0,0,0,32.3,35.5,67.8,NA,None
Ponsegromab,Gallstones,Gallstones,0,0,0,0,0,29.5,38.3,67.8,475116,None
Ponsegromab,Persistent Infection,Persistent Infection,0,0,0,0,0,22,45.8,67.8,976916,None
Ponsegromab,Pure Red-Cell Aplasia,Pure Red-Cell Aplasia,0,0,0,0,0,38.5,29.2,67.8,NA,None
Ponsegromab,Secondary Immunodeficiencies,Secondary Immunodeficiencies,0,0,0,0,0,33.8,34,67.8,NA,None
Ponsegromab,Carotid Artery Diseases,Carotid Artery Diseases,0,0,0,0,0,35.7,32,67.7,150024,None
Ponsegromab,Pediatric Obesity,Pediatric Obesity,0,0,0,0,0,17.4,50.3,67.7,6408141,None
Ponsegromab,Heart Septal Defects,Heart Septal Defects,0,0,0,0,0,29.7,38,67.6,NA,None
Ponsegromab,Hypoglycemia,Hypoglycemia,0,0,0,0,0,31.8,35.9,67.6,23386,None
Ponsegromab,Transposition of Great Vessels,Transposition of Great Vessels,0,0,0,0,0,30.9,36.7,67.6,NA,None
Ponsegromab,Cholecystolithiasis,Cholecystolithiasis,0,0,0,0,0,29.4,38.1,67.5,475116,None
Ponsegromab,Cranial Nerve Diseases,Cranial Nerve Diseases,0,0,0,0,0,41.3,26.2,67.5,NA,None
Ponsegromab,Macrocytic Anemia,Macrocytic Anemia,0,0,0,0,0,41.8,25.7,67.5,NA,None
Ponsegromab,Progressive Myoclonic Epilepsies,Progressive Myoclonic Epilepsies,0,0,0,0,0,18,49.5,67.5,1242619,None
Ponsegromab,Traumatic Brain Injury (TBI),Traumatic Brain Injury (TBI),0,0,0,0,0,26.9,40.6,67.5,81849,None
Ponsegromab,Trophoblastic Neoplasms,Trophoblastic Neoplasms,0,0,0,0,0,33.6,33.9,67.5,NA,None
Ponsegromab,Neutropenia,Neutropenia,0,0,0,0,0,32.9,34.4,67.3,32564,None
Ponsegromab,Hydatidiform Mole,Hydatidiform Mole,0,0,0,0,0,38,29.2,67.2,327,None
Ponsegromab,Streptococcal Infections,Streptococcal Infections,0,0,0,0,0,18.7,48.5,67.2,1944266,None
Ponsegromab,Gastroesophageal Junction (GEJ) Cancer,Gastroesophageal Junction (GEJ) Cancer,0,0,0,0,0,25.1,42,67.1,NA,None
Ponsegromab,Lysosomal Storage Diseases,Lysosomal Storage Diseases,0,0,0,0,0,33.1,34,67.1,45890,None
Ponsegromab,Chronic Progressive External Ophthalmoplegia,Chronic Progressive External Ophthalmoplegia,0,0,0,0,0,35.9,31.1,67,NA,None
Ponsegromab,Endocrine Bone Diseases,Endocrine Bone Diseases,0,0,0,0,0,20,47,67,9886949,None
Ponsegromab,Nephrocalcinosis,Nephrocalcinosis,0,0,0,0,0,30.7,36.3,67,324666,None
Ponsegromab,Dyskinesias,Dyskinesias,0,0,0,0,0,36.1,30.8,66.9,NA,None
Ponsegromab,Sphingolipidoses,Sphingolipidoses,0,0,0,0,0,34.9,32.1,66.9,NA,None
Ponsegromab,Congenital Hypoplastic Anemia,Congenital Hypoplastic Anemia,0,0,0,0,0,35,31.8,66.8,NA,None
Ponsegromab,DNA Repair-Deficiency Disorders,DNA Repair-Deficiency Disorders,0,0,0,0,0,27.1,39.6,66.8,NA,None
Ponsegromab,Bone Fractures,Bone Fractures,0,0,0,0,0,42.3,24.4,66.7,NA,None
Ponsegromab,Congenital Adrenal Hyperplasia,Congenital Adrenal Hyperplasia,0,0,0,0,0,40.9,25.8,66.7,16370,None
Ponsegromab,Eclampsia,Eclampsia,0,0,0,0,0,39.9,26.7,66.6,NA,None
Ponsegromab,Goiter,Goiter,0,0,0,0,0,31.2,35.4,66.6,864685,None
Ponsegromab,Hypokalemia,Hypokalemia,0,0,0,0,0,27.7,38.9,66.6,2888507,None
Ponsegromab,Fanconi Anemia,Fanconi Anemia,0,0,0,0,0,24.5,42,66.5,1637,None
Ponsegromab,Neoplastic Complications in Pregnancy,Neoplastic Complications in Pregnancy,0,0,0,0,0,32.7,33.7,66.5,2121796,None
Ponsegromab,Decompensated Cirrhosis,Decompensated Cirrhosis,0,0,0,0,0,21,45.4,66.4,NA,None
Ponsegromab,Age of Onset,Age of Onset,0,0,0,0,0,37.4,28.9,66.3,NA,None
Ponsegromab,Age-Related Macular Degeneration (AMD),Age-Related Macular Degeneration (AMD),0,0,0,0,0,29.2,37.1,66.3,167529,None
Ponsegromab,Fibromyalgia,Fibromyalgia,0,0,0,0,0,24.7,41.6,66.3,144249420,None
Ponsegromab,Gastroesophageal Adenocarcinoma (GEA),Gastroesophageal Adenocarcinoma (GEA),0,0,0,0,0,39.9,26.4,66.3,NA,None
Ponsegromab,Severe Aplastic Anemia,Severe Aplastic Anemia,0,0,0,0,0,20.7,45.6,66.3,NA,None
Ponsegromab,Monogenic Diabetes,Monogenic Diabetes,0,0,0,0,0,34.8,31.4,66.2,NA,None
Ponsegromab,Myoma,Myoma,0,0,0,0,0,31.8,34.4,66.2,222015,None
Ponsegromab,Osteoarticular Tuberculosis,Osteoarticular Tuberculosis,0,0,0,0,0,28.9,37.3,66.2,NA,None
Ponsegromab,Atopic Dermatitis,Atopic Dermatitis,0,0,0,0,0,32.7,33.4,66.1,8595515,None
Ponsegromab,Candidiasis,Candidiasis,0,0,0,0,0,31.4,34.8,66.1,1908068,None
Ponsegromab,Dyssomnias,Dyssomnias,0,0,0,0,0,28.9,37.1,66,15439078,None
Ponsegromab,Central Nervous System Cavernous Hemangioma,Central Nervous System Cavernous Hemangioma,0,0,0,0,0,27.9,37.9,65.9,NA,None
Ponsegromab,Hip Osteoarthritis,Hip Osteoarthritis,0,0,0,0,0,26.1,39.8,65.9,234796,None
Ponsegromab,Transient Ischemic Attack (TIA),Transient Ischemic Attack (TIA),0,0,0,0,0,37.4,28.5,65.9,NA,None
Ponsegromab,Atrophic Gastritis,Atrophic Gastritis,0,0,0,0,0,29.2,36.7,65.8,950045,None
Ponsegromab,Cholelithiasis,Cholelithiasis,0,0,0,0,0,28.2,37.6,65.8,475116,None
Ponsegromab,Congenital Bone Marrow Failure Syndromes,Congenital Bone Marrow Failure Syndromes,0,0,0,0,0,34.7,31.1,65.8,NA,None
Ponsegromab,Alcoholic Hepatitis,Alcoholic Hepatitis,0,0,0,0,0,15.3,50.3,65.7,NA,None
Ponsegromab,Allergies (Immediate Hypersensitivity),Allergies (Immediate Hypersensitivity),0,0,0,0,0,39.5,26.2,65.7,NA,None
Ponsegromab,Intracranial Hypertension,Intracranial Hypertension,0,0,0,0,0,31.5,34.2,65.7,81849,None
Ponsegromab,Peritoneal Cancer/Metastases,Peritoneal Cancer/Metastases,0,0,0,0,0,24.1,41.6,65.7,NA,None
Ponsegromab,Skin Ulcer,Skin Ulcer,0,0,0,0,0,20.2,45.5,65.7,4549237,None
Ponsegromab,Tricuspid Valve Insufficiency,Tricuspid Valve Insufficiency,0,0,0,0,0,25.3,40.4,65.7,NA,None
Ponsegromab,Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD),Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD),0,0,0,0,0,31.5,34.1,65.6,NA,None
Ponsegromab,Fetal Growth Restriction,Fetal Growth Restriction,0,0,0,0,0,27.8,37.8,65.6,NA,None
Ponsegromab,Pigmentation Disorders,Pigmentation Disorders,0,0,0,0,0,30.7,35,65.6,494158,None
Ponsegromab,Urinary Tract Infections (UTI),Urinary Tract Infections (UTI),0,0,0,0,0,24.6,40.9,65.5,507386,None
Ponsegromab,Back Pain,Back Pain,0,0,0,0,0,21.1,44.4,65.4,18204986,None
Ponsegromab,Chronic Wounds,Chronic Wounds,0,0,0,0,0,39.4,25.9,65.4,NA,None
Ponsegromab,Gastroenteritis,Gastroenteritis,0,0,0,0,0,24.6,40.8,65.4,653360,None
Ponsegromab,Immunoglobulin G4 (IgG4)-Related Disease,Immunoglobulin G4 (IgG4)-Related Disease,0,0,0,0,0,22.9,42.4,65.4,327,None
Ponsegromab,Myelodysplastic-Myeloproliferative Diseases (MDS/MPN),Myelodysplastic-Myeloproliferative Diseases (MDS/MPN),0,0,0,0,0,37.1,28.2,65.4,NA,None
Ponsegromab,Pneumovirus Infections,Pneumovirus Infections,0,0,0,0,0,27.4,38,65.4,NA,None
Ponsegromab,Renal Cell Carcinoma (RCC),Renal Cell Carcinoma (RCC),0,0,0,0,0,22.3,43,65.4,81849,None
Ponsegromab,Unresectable Tumors,Unresectable Tumors,0,0,0,0,0,37.4,28,65.4,NA,None
Ponsegromab,Escherichia coli Infections,Escherichia coli Infections,0,0,0,0,0,32.5,32.9,65.3,NA,None
Ponsegromab,Extrinsic Allergic Alveolitis,Extrinsic Allergic Alveolitis,0,0,0,0,0,29.4,35.9,65.3,NA,None
Ponsegromab,Limited Scleroderma,Limited Scleroderma,0,0,0,0,0,18.2,47.2,65.3,190066,None
Ponsegromab,Primary Biliary Cholangitis (PBC),Primary Biliary Cholangitis (PBC),0,0,0,0,0,17.1,48.2,65.3,81849,None
Ponsegromab,Tuberculosis,Tuberculosis,0,0,0,0,0,28.8,36.6,65.3,36821459,None
Ponsegromab,Relapsed/Refractory Hematologic Malignancies,Relapsed/Refractory Hematologic Malignancies,0,0,0,0,0,32.2,32.9,65.2,NA,None
Ponsegromab,Leg Injuries,Leg Injuries,0,0,0,0,0,35.5,29.5,65.1,NA,None
Ponsegromab,Helicobacter Pylori,Helicobacter Pylori,0,0,0,0,0,33,32,65,950045,None
Ponsegromab,Foot Diseases,Foot Diseases,0,0,0,0,0,16.4,48.5,64.9,11102007,None
Ponsegromab,Heart Injuries,Heart Injuries,0,0,0,0,0,36.8,28.1,64.9,NA,None
Ponsegromab,Hemodynamic Instability,Hemodynamic Instability,0,0,0,0,0,35.3,29.5,64.9,NA,None
Ponsegromab,Xerostomia,Xerostomia,0,0,0,0,0,29.2,35.6,64.9,47843,None
Ponsegromab,Viral Lower Respiratory Tract Infections,Viral Lower Respiratory Tract Infections,0,0,0,0,0,36.8,27.9,64.8,NA,None
Ponsegromab,Cholestatic Liver Diseases,Cholestatic Liver Diseases,0,0,0,0,0,32.4,32.4,64.7,NA,None
Ponsegromab,Spondylosis,Spondylosis,0,0,0,0,0,25.2,39.5,64.7,91760,None
Ponsegromab,Hemochromatosis,Hemochromatosis,0,0,0,0,0,24.4,40,64.5,296860,None
Ponsegromab,Ketosis,Ketosis,0,0,0,0,0,44,20.6,64.5,45890,None
Ponsegromab,Megacolon,Megacolon,0,0,0,0,0,23.2,41.3,64.5,2937754,None
Ponsegromab,Erythroblastosis Fetalis,Erythroblastosis Fetalis,0,0,0,0,0,38.6,25.7,64.4,NA,None
Ponsegromab,Intracranial Arterial Diseases,Intracranial Arterial Diseases,0,0,0,0,0,29,35.4,64.4,NA,None
Ponsegromab,Pancreatic Cyst,Pancreatic Cyst,0,0,0,0,0,27.8,36.7,64.4,327,None
Ponsegromab,Testicular Diseases,Testicular Diseases,0,0,0,0,0,40.8,23.6,64.4,101218,None
Ponsegromab,Germ-Cell Tumors,Germ-Cell Tumors,0,0,0,0,0,20,44.4,64.3,327,None
Ponsegromab,Habitual Abortion,Habitual Abortion,0,0,0,0,0,33.1,31.2,64.3,NA,None
Ponsegromab,Hemangioma,Hemangioma,0,0,0,0,0,24,40.2,64.2,NA,None
Ponsegromab,Bone Marrow Failure,Bone Marrow Failure,0,0,0,0,0,37.7,26.4,64.1,NA,None
Ponsegromab,Central Nervous System Vascular Malformations,Central Nervous System Vascular Malformations,0,0,0,0,0,24.3,39.9,64.1,NA,None
Ponsegromab,Strongylida Infections,Strongylida Infections,0,0,0,0,0,38.7,25.4,64.1,NA,None
Ponsegromab,Takotsubo Cardiomyopathy,Takotsubo Cardiomyopathy,0,0,0,0,0,18.2,45.9,64.1,16370,None
Ponsegromab,Ear Diseases,Ear Diseases,0,0,0,0,0,31.6,32.3,64,995051,None
Ponsegromab,Bile Duct Diseases,Bile Duct Diseases,0,0,0,0,0,30.1,33.9,63.9,NA,None
Ponsegromab,MINOCA,MINOCA,0,0,0,0,0,10.4,53.5,63.9,4844922,None
Ponsegromab,Portal Hypertension,Portal Hypertension,0,0,0,0,0,20.1,43.8,63.9,1041348,None
Ponsegromab,Parasitic Diseases,Parasitic Diseases,0,0,0,0,0,38.6,25.1,63.7,NA,None
Ponsegromab,Retinal Neoplasms,Retinal Neoplasms,0,0,0,0,0,30.3,33.2,63.6,2121796,None
Ponsegromab,Thiamine Deficiency,Thiamine Deficiency,0,0,0,0,0,37.6,25.9,63.6,NA,None
Ponsegromab,Central Sleep Apnea,Central Sleep Apnea,0,0,0,0,0,14.8,48.7,63.5,15439078,None
Ponsegromab,Disorders of Sex Development,Disorders of Sex Development,0,0,0,0,0,34.9,28.6,63.5,1427302,None
Ponsegromab,Alcoholic Liver Cirrhosis,Alcoholic Liver Cirrhosis,0,0,0,0,0,20.7,42.7,63.4,716004,None
Ponsegromab,Leukocyte Disorders,Leukocyte Disorders,0,0,0,0,0,34.4,29,63.4,32564,None
Ponsegromab,Cockayne Syndrome,Cockayne Syndrome,0,0,0,0,0,26.9,36.3,63.3,327,None
Ponsegromab,Gestational Trophoblastic Neoplasia,Gestational Trophoblastic Neoplasia,0,0,0,0,0,34.7,28.6,63.3,NA,None
Ponsegromab,Heart Rupture,Heart Rupture,0,0,0,0,0,37.2,26.1,63.3,NA,None
Ponsegromab,Multiple System Atrophy,Multiple System Atrophy,0,0,0,0,0,20.7,42.7,63.3,16370,None
Ponsegromab,Retinoblastoma,Retinoblastoma,0,0,0,0,0,30.5,32.8,63.3,16370,None
Ponsegromab,Water Intoxication,Water Intoxication,0,0,0,0,0,16.9,46.4,63.3,2888507,None
Ponsegromab,Autoimmune Skin Disorders,Autoimmune Skin Disorders,0,0,0,0,0,37.2,26,63.1,NA,None
Ponsegromab,Restrictive Cardiomyopathy (RCM),Restrictive Cardiomyopathy (RCM),0,0,0,0,0,26.6,36.6,63.1,327,None
Ponsegromab,Acneiform Eruptions (Acne),Acneiform Eruptions (Acne),0,0,0,0,0,29.8,33.1,62.9,3219289,None
Ponsegromab,Cavernous Hemangioma,Cavernous Hemangioma,0,0,0,0,0,26.5,36.5,62.9,NA,None
Ponsegromab,Cardiovascular Infections,Cardiovascular Infections,0,0,0,0,0,16.4,46.3,62.7,976916,None
Ponsegromab,Congenitally Corrected Transposition of the Great Arteries,Congenitally Corrected Transposition of the Great Arteries,0,0,0,0,0,31.7,30.9,62.6,16370,None
Ponsegromab,Chronic Pain,Chronic Pain,0,0,0,0,0,23.8,38.8,62.5,3944607,None
Ponsegromab,Endometriosis,Endometriosis,0,0,0,0,0,28.5,34,62.5,589002,None
Ponsegromab,Genetic Skin Diseases,Genetic Skin Diseases,0,0,0,0,0,33.3,29.2,62.5,NA,None
Ponsegromab,Papulosquamous Skin Diseases,Papulosquamous Skin Diseases,0,0,0,0,0,36.6,25.9,62.5,NA,None
Ponsegromab,Biliary Liver Cirrhosis,Biliary Liver Cirrhosis,0,0,0,0,0,17.2,45.2,62.4,190066,None
Ponsegromab,Infertility,Infertility,0,0,0,0,0,32.5,29.8,62.3,NA,None
Ponsegromab,Gingival Hyperplasia,Gingival Hyperplasia,0,0,0,0,0,26.4,35.8,62.2,770994,None
Ponsegromab,Hypercholesterolemia,Hypercholesterolemia,0,0,0,0,0,25.5,36.7,62.2,1637,None
Ponsegromab,Norovirus,Norovirus,0,0,0,0,0,28.1,34,62.1,NA,None
Ponsegromab,Gestational Hypertension,Gestational Hypertension,0,0,0,0,0,34.2,27.8,62,NA,None
Ponsegromab,Biliary Atresia,Biliary Atresia,0,0,0,0,0,26,36,61.9,81849,None
Ponsegromab,Lymphomas,Lymphomas,0,0,0,0,0,14.3,47.6,61.9,431983,None
Ponsegromab,Refeeding Syndrome,Refeeding Syndrome,0,0,0,0,0,36.2,25.7,61.9,NA,None
Ponsegromab,Syncope,Syncope,0,0,0,0,0,18.1,43.9,61.9,674740,None
Ponsegromab,Gastroparesis,Gastroparesis,0,0,0,0,0,12.2,49.7,61.8,81849,None
Ponsegromab,Pericardial Effusion,Pericardial Effusion,0,0,0,0,0,26.2,35.6,61.8,NA,None
Ponsegromab,Tetralogy of Fallot,Tetralogy of Fallot,0,0,0,0,0,26.2,35.6,61.8,81849,None
Ponsegromab,Myoclonic Epilepsies,Myoclonic Epilepsies,0,0,0,0,0,15.4,46.3,61.7,3137593,None
Ponsegromab,Sinusitis,Sinusitis,0,0,0,0,0,25.5,36.2,61.7,8216633,None
Ponsegromab,Bone Lesion,Bone Lesion,0,0,0,0,0,29.6,32,61.6,NA,None
Ponsegromab,Adrenogenital Syndrome,Adrenogenital Syndrome,0,0,0,0,0,37.5,24,61.5,NA,None
Ponsegromab,Growth Deficiency in Children,Growth Deficiency in Children,0,0,0,0,0,17.6,43.9,61.5,1427302,None
Ponsegromab,Desmoplastic Melanoma,Desmoplastic Melanoma,0,0,0,0,0,26.9,34.4,61.4,231126,None
Ponsegromab,Carcinoma in Situ,Carcinoma in Situ,0,0,0,0,0,32.6,28.7,61.3,NA,None
Ponsegromab,Visceral Pain Diseases,Visceral Pain Diseases,0,0,0,0,0,31.7,29.6,61.3,NA,None
Ponsegromab,Hip Injuries,Hip Injuries,0,0,0,0,0,33.9,27.3,61.2,NA,None
Ponsegromab,Optic Atrophy,Optic Atrophy,0,0,0,0,0,29,32.2,61.2,NA,None
Ponsegromab,Typhoid,Typhoid,0,0,0,0,0,27.5,33.7,61.2,15,None
Ponsegromab,Uterine Cervical Diseases,Uterine Cervical Diseases,0,0,0,0,0,35.6,25.6,61.2,NA,None
Ponsegromab,Allergic Rhinitis,Allergic Rhinitis,0,0,0,0,0,26.5,34.6,61.1,5948198,None
Ponsegromab,Inborn Errors of Purine-Pyrimidine Metabolism,Inborn Errors of Purine-Pyrimidine Metabolism,0,0,0,0,0,35.8,25.3,61.1,NA,None
Ponsegromab,Malabsorption Syndromes,Malabsorption Syndromes,0,0,0,0,0,24.9,36.2,61.1,54965,None
Ponsegromab,Propionic Acidemia,Propionic Acidemia,0,0,0,0,0,22.1,39.1,61.1,16370,None
Ponsegromab,Gingival Overgrowth,Gingival Overgrowth,0,0,0,0,0,26.4,34.6,61,96123,None
Ponsegromab,Wound Complications,Wound Complications,0,0,0,0,0,29,32,61,NA,None
Ponsegromab,Adrenocortical Carcinoma,Adrenocortical Carcinoma,0,0,0,0,0,13.2,47.6,60.8,1637,None
Ponsegromab,Arthralgia (Joint Pain),Arthralgia (Joint Pain),0,0,0,0,0,15.3,45.5,60.8,22081614,None
Ponsegromab,Nose Diseases,Nose Diseases,0,0,0,0,0,30.8,30,60.8,2427708,None
Ponsegromab,Temporomandibular Joint Disorders,Temporomandibular Joint Disorders,0,0,0,0,0,20.9,39.9,60.8,217325,None
Ponsegromab,Craniomandibular Disorders,Craniomandibular Disorders,0,0,0,0,0,20.9,39.9,60.7,217325,None
Ponsegromab,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,0,0,0,0,0,26.6,34.1,60.6,1637,None
Ponsegromab,Neuroendocrine Tumors (NETs),Neuroendocrine Tumors (NETs),0,0,0,0,0,32.8,27.8,60.6,NA,None
Ponsegromab,Essential Thrombocythemia,Essential Thrombocythemia,0,0,0,0,0,12.1,48.4,60.5,81849,None
Ponsegromab,Febrile Seizures,Febrile Seizures,0,0,0,0,0,22.6,37.9,60.5,1749202,None
Ponsegromab,Haemangioendothelioma,Haemangioendothelioma,0,0,0,0,0,10.2,50.2,60.5,493475,None
Ponsegromab,Follicular Adenocarcinoma,Follicular Adenocarcinoma,0,0,0,0,0,30,30.4,60.4,NA,None
Ponsegromab,Progressive Supranuclear Palsy (PSP),Progressive Supranuclear Palsy (PSP),0,0,0,0,0,12.7,47.7,60.4,16370,None
Ponsegromab,Status Epilepticus,Status Epilepticus,0,0,0,0,0,23.7,36.6,60.3,327,None
Ponsegromab,Infectious Pneumonia,Infectious Pneumonia,0,0,0,0,0,22.7,37.6,60.2,NA,None
Ponsegromab,Multiple Primary Neoplasms,Multiple Primary Neoplasms,0,0,0,0,0,24.1,36,60.2,NA,None
Ponsegromab,Cardiovascular Complications,Cardiovascular Complications,0,0,0,0,0,32.6,27.4,60.1,NA,None
Ponsegromab,Diabetic Retinopathy,Diabetic Retinopathy,0,0,0,0,0,24.1,36.1,60.1,NA,None
Ponsegromab,Lymphopenia,Lymphopenia,0,0,0,0,0,17.8,42.3,60.1,32564,None
Ponsegromab,Optic Nerve Diseases,Optic Nerve Diseases,0,0,0,0,0,33.9,26.2,60.1,NA,None
Ponsegromab,Polycythemia Vera,Polycythemia Vera,0,0,0,0,0,14.7,45.4,60.1,81849,None
Ponsegromab,Behcet's Disease,Behcet's Disease,0,0,0,0,0,16.8,43.2,60,703684,None
Ponsegromab,Sepsis-Associated Acute Kidney Injury,Sepsis-Associated Acute Kidney Injury,0,0,0,0,0,27.6,32.4,60,NA,None
Ponsegromab,Adrenal Cortex Neoplasms,Adrenal Cortex Neoplasms,0,0,0,0,0,14.6,45.2,59.9,2121796,None
Ponsegromab,Mycobacterium Infections,Mycobacterium Infections,0,0,0,0,0,28.5,31.4,59.9,NA,None
Ponsegromab,Prescription Drug Overuse,Prescription Drug Overuse,0,0,0,0,0,30.3,29.7,59.9,NA,None
Ponsegromab,Food Hypersensitivity (Food Allergy),Food Hypersensitivity (Food Allergy),0,0,0,0,0,10.8,48.9,59.7,11808153,None
Ponsegromab,Primitive Neuroectodermal Tumors,Primitive Neuroectodermal Tumors,0,0,0,0,0,31.6,28,59.7,NA,None
Ponsegromab,Unstable Angina,Unstable Angina,0,0,0,0,0,25.7,34,59.7,1655376,None
Ponsegromab,Adrenal Tumors,Adrenal Tumors,0,0,0,0,0,14.5,45.1,59.6,2121796,None
Ponsegromab,Bone Tissue Neoplasms,Bone Tissue Neoplasms,0,0,0,0,0,14.7,44.7,59.4,NA,None
Ponsegromab,Cardiac Conduction System Disease,Cardiac Conduction System Disease,0,0,0,0,0,25.6,33.8,59.4,NA,None
Ponsegromab,"Encephalitis, Myelitis and Encephalomyelitis","Encephalitis, Myelitis and Encephalomyelitis",0,0,0,0,0,32,27.5,59.4,NA,None
Ponsegromab,Pseudomonas aeruginosa,Pseudomonas aeruginosa,0,0,0,0,0,28.5,30.8,59.4,81849,None
Ponsegromab,Pharyngeal Diseases,Pharyngeal Diseases,0,0,0,0,0,23.7,35.6,59.3,938407,None
Ponsegromab,Adrenal Cortex Diseases,Adrenal Cortex Diseases,0,0,0,0,0,14.6,44.6,59.2,NA,None
Ponsegromab,Cholangitis,Cholangitis,0,0,0,0,0,14.8,44.4,59.2,81849,None
Ponsegromab,Chronic Chemical and Drug Induced Liver Injury,Chronic Chemical and Drug Induced Liver Injury,0,0,0,0,0,26.8,32.4,59.2,NA,None
Ponsegromab,Cardiac Tumors,Cardiac Tumors,0,0,0,0,0,25.8,33.3,59.1,2121796,None
Ponsegromab,Perinatal Depression (Postpartum Depression),Perinatal Depression (Postpartum Depression),0,0,0,0,0,26.4,32.6,59,NA,None
Ponsegromab,Blood Coagulation Disorders,Blood Coagulation Disorders,0,0,0,0,0,20,38.9,58.9,141993,None
Ponsegromab,Chronic Thromboembolic Pulmonary Hypertension (CTEPH),Chronic Thromboembolic Pulmonary Hypertension (CTEPH),0,0,0,0,0,24.6,34,58.6,NA,None
Ponsegromab,Patent Foramen Ovale,Patent Foramen Ovale,0,0,0,0,0,23,35.5,58.6,NA,None
Ponsegromab,Schizophrenia,Schizophrenia,0,0,0,0,0,24.3,34.3,58.6,1605094,None
Ponsegromab,Delta Thalassemia,Delta Thalassemia,0,0,0,0,0,26.7,31.7,58.5,327,None
Ponsegromab,Excessive Daytime Sleepiness (Hypersomnia),Excessive Daytime Sleepiness (Hypersomnia),0,0,0,0,0,17.6,40.9,58.5,15439078,None
Ponsegromab,Gingival Diseases,Gingival Diseases,0,0,0,0,0,27.7,30.8,58.5,96123,None
Ponsegromab,Hemosiderosis,Hemosiderosis,0,0,0,0,0,22.6,35.9,58.5,327,None
Ponsegromab,Prenatal Injuries,Prenatal Injuries,0,0,0,0,0,29.2,29.4,58.5,NA,None
Ponsegromab,Acromegaly,Acromegaly,0,0,0,0,0,19.4,39,58.4,16370,None
Ponsegromab,Actinomycetales Infections,Actinomycetales Infections,0,0,0,0,0,30.1,28.2,58.4,327,None
Ponsegromab,Chronic Rhinosinusitis with Nasal Polyps (CRSwNP),Chronic Rhinosinusitis with Nasal Polyps (CRSwNP),0,0,0,0,0,28.3,30.2,58.4,NA,None
Ponsegromab,Major Depressive Disorder (MDD) (incl. PPD),Major Depressive Disorder (MDD) (incl. PPD),0,0,0,0,0,33,25.4,58.4,NA,None
Ponsegromab,Obstetric Labor Complications,Obstetric Labor Complications,0,0,0,0,0,22.9,35.4,58.4,218086,None
Ponsegromab,Autonomic Nervous System Diseases,Autonomic Nervous System Diseases,0,0,0,0,0,17.2,41.1,58.3,NA,None
Ponsegromab,Intra-Abdominal Infections (IAI),Intra-Abdominal Infections (IAI),0,0,0,0,0,14.9,43.3,58.3,203126,None
Ponsegromab,Minimal Change Disease,Minimal Change Disease,0,0,0,0,0,14.8,43.5,58.3,NA,None
Ponsegromab,Autoimmune Hemolytic Anemia (AIHA),Autoimmune Hemolytic Anemia (AIHA),0,0,0,0,0,13.8,44.4,58.2,81849,None
Ponsegromab,Central Nervous System Infections,Central Nervous System Infections,0,0,0,0,0,15.7,42.5,58.2,976916,None
Ponsegromab,Embryo Loss,Embryo Loss,0,0,0,0,0,26.9,31.3,58.2,4136,None
Ponsegromab,Cytomegalovirus Infections,Cytomegalovirus Infections,0,0,0,0,0,13.7,44.4,58.1,NA,None
Ponsegromab,Neurodevelopmental Disorders,Neurodevelopmental Disorders,0,0,0,0,0,32,26.2,58.1,NA,None
Ponsegromab,Chronic Total Occlusion (CTO),Chronic Total Occlusion (CTO),0,0,0,0,0,11.5,46.5,58,8139256,None
Ponsegromab,Williams Syndrome,Williams Syndrome,0,0,0,0,0,25.6,32.4,58,81849,None
Ponsegromab,Endomyocardial Fibrosis,Endomyocardial Fibrosis,0,0,0,0,0,25.2,32.6,57.9,327,None
Ponsegromab,Facial Scar,Facial Scar,0,0,0,0,0,31.7,26.2,57.9,NA,None
Ponsegromab,Ventricular Tachycardia,Ventricular Tachycardia,0,0,0,0,0,26.3,31.7,57.9,44988,None
Ponsegromab,Celiac Disease,Celiac Disease,0,0,0,0,0,23.3,34.5,57.8,327,None
Ponsegromab,Autosomal Dominant Optic Atrophy,Autosomal Dominant Optic Atrophy,0,0,0,0,0,26.7,31,57.7,245548,None
Ponsegromab,Supravalvular Aortic Stenosis,Supravalvular Aortic Stenosis,0,0,0,0,0,25.4,32.3,57.7,NA,None
Ponsegromab,B-Cell Non-Hodgkin's Lymphoma,B-Cell Non-Hodgkin's Lymphoma,0,0,0,0,0,8.8,48.8,57.6,81849,None
Ponsegromab,Leukocytosis,Leukocytosis,0,0,0,0,0,22.5,35,57.6,32564,None
Ponsegromab,Epithelioid Hemangioendothelioma,Epithelioid Hemangioendothelioma,0,0,0,0,0,10.9,46.6,57.5,327,None
Ponsegromab,Cross Infection,Cross Infection,0,0,0,0,0,12.2,45.2,57.4,976916,None
Ponsegromab,Digestive System Abnormalities,Digestive System Abnormalities,0,0,0,0,0,24.9,32.4,57.4,NA,None
Ponsegromab,Autoimmune Encephalitis,Autoimmune Encephalitis,0,0,0,0,0,20.1,37.1,57.2,327,None
Ponsegromab,Ulcerative Colitis,Ulcerative Colitis,0,0,0,0,0,15.7,41.5,57.2,180231,None
Ponsegromab,Hepatic Porphyrias,Hepatic Porphyrias,0,0,0,0,0,23.8,33.2,57.1,NA,None
Ponsegromab,Hereditary Optic Atrophies,Hereditary Optic Atrophies,0,0,0,0,0,27.6,29.5,57.1,NA,None
Ponsegromab,Developmental Bone Diseases,Developmental Bone Diseases,0,0,0,0,0,25,31.9,57,654874,None
Ponsegromab,Cytomegalovirus (CMV),Cytomegalovirus (CMV),0,0,0,0,0,10.9,46,56.9,81849,None
Ponsegromab,Spondyloarthropathies,Spondyloarthropathies,0,0,0,0,0,17.5,39.5,56.9,2879542,None
Ponsegromab,Iris Diseases,Iris Diseases,0,0,0,0,0,33.9,22.8,56.8,NA,None
Ponsegromab,Melanosis,Melanosis,0,0,0,0,0,30,26.8,56.8,494158,None
Ponsegromab,Non-Hodgkin's Lymphoma (NHL),Non-Hodgkin's Lymphoma (NHL),0,0,0,0,0,10,46.8,56.8,288966,None
Ponsegromab,Premature Menopause,Premature Menopause,0,0,0,0,0,20.4,36.4,56.8,715422,None
Ponsegromab,Lens Diseases,Lens Diseases,0,0,0,0,0,31.6,25.1,56.7,NA,None
Ponsegromab,Bone Marrow Neoplasms,Bone Marrow Neoplasms,0,0,0,0,0,14.6,42.1,56.6,2121796,None
Ponsegromab,Fragility Fracture,Fragility Fracture,0,0,0,0,0,26.4,30.2,56.6,NA,None
Ponsegromab,Dental Deposits,Dental Deposits,0,0,0,0,0,22.8,33.7,56.5,30563,None
Ponsegromab,Osteosarcoma,Osteosarcoma,0,0,0,0,0,16.1,40.4,56.5,16370,None
Ponsegromab,Solitary Pulmonary Nodule,Solitary Pulmonary Nodule,0,0,0,0,0,16.6,39.9,56.5,530055,None
Ponsegromab,Burns,Burns,0,0,0,0,0,22.2,34.2,56.4,25664,None
Ponsegromab,Erythropoietic Protoporphyria (EPP),Erythropoietic Protoporphyria (EPP),0,0,0,0,0,25.6,30.8,56.4,NA,None
Ponsegromab,TP53 mutated Exocrine Pancreatic Cancer,TP53 mutated Exocrine Pancreatic Cancer,0,0,0,0,0,27.2,29.1,56.4,NA,None
Ponsegromab,Human Papillomavirus (HPV),Human Papillomavirus (HPV),0,0,0,0,0,26.3,30,56.3,NA,None
Ponsegromab,Urogenital Abnormalities,Urogenital Abnormalities,0,0,0,0,0,33,23.3,56.3,163482,None
Ponsegromab,Bacteremia,Bacteremia,0,0,0,0,0,35.1,21.2,56.2,NA,None
Ponsegromab,Hyperpigmentation,Hyperpigmentation,0,0,0,0,0,28.3,28,56.2,494158,None
Ponsegromab,Nephrotic Syndrome,Nephrotic Syndrome,0,0,0,0,0,25.8,30.4,56.2,NA,None
Ponsegromab,Inborn Errors of Metal Metabolism,Inborn Errors of Metal Metabolism,0,0,0,0,0,27.1,29,56.1,296860,None
Ponsegromab,Insomnia,Insomnia,0,0,0,0,0,20.7,35.4,56.1,15439078,None
Ponsegromab,Antiphospholipid Syndrome (APS),Antiphospholipid Syndrome (APS),0,0,0,0,0,14.2,41.8,56,141993,None
Ponsegromab,Arrhythmogenic Cardiomyopathy,Arrhythmogenic Cardiomyopathy,0,0,0,0,0,9.8,46,55.8,81849,None
Ponsegromab,Colitis,Colitis,0,0,0,0,0,14.7,41.1,55.8,653360,None
Ponsegromab,Neuromyelitis Optica Spectrum Disorder (NMOSD),Neuromyelitis Optica Spectrum Disorder (NMOSD),0,0,0,0,0,16.8,38.9,55.8,16370,None
Ponsegromab,Polycythemia,Polycythemia,0,0,0,0,0,13.5,42.3,55.8,81849,None
Ponsegromab,Cushing Syndrome (Hypercortisolism),Cushing Syndrome (Hypercortisolism),0,0,0,0,0,13.2,42.6,55.7,327,None
Ponsegromab,Prescription Drug Misuse,Prescription Drug Misuse,0,0,0,0,0,25.7,30,55.7,NA,None
Ponsegromab,Dermatomyositis,Dermatomyositis,0,0,0,0,0,21,34.6,55.6,16370,None
Ponsegromab,Salmonella Infections,Salmonella Infections,0,0,0,0,0,25,30.6,55.6,51,None
Ponsegromab,Crystal Arthropathies,Crystal Arthropathies,0,0,0,0,0,35.5,20,55.5,NA,None
Ponsegromab,Drug Misuse,Drug Misuse,0,0,0,0,0,25.6,29.9,55.5,NA,None
Ponsegromab,Porphyrias,Porphyrias,0,0,0,0,0,23.2,32.2,55.5,1637,None
Ponsegromab,MERRF Syndrome,MERRF Syndrome,0,0,0,0,0,18.2,37.2,55.4,1637,None
Ponsegromab,Tracheal Stenosis,Tracheal Stenosis,0,0,0,0,0,14,41.3,55.4,16370,None
Ponsegromab,Chronic Rhinosinusitis (CRS),Chronic Rhinosinusitis (CRS),0,0,0,0,0,26.1,29.2,55.3,NA,None
Ponsegromab,Dental Enamel Hypoplasia,Dental Enamel Hypoplasia,0,0,0,0,0,26.4,28.9,55.3,27806,None
Ponsegromab,Disorders of Excessive Somnolence,Disorders of Excessive Somnolence,0,0,0,0,0,16.7,38.6,55.3,15439078,None
Ponsegromab,Pelvic Infection,Pelvic Infection,0,0,0,0,0,19.2,36.1,55.3,NA,None
Ponsegromab,Amelogenesis Imperfecta,Amelogenesis Imperfecta,0,0,0,0,0,27,28.2,55.2,245548,None
Ponsegromab,Epileptic Syndromes,Epileptic Syndromes,0,0,0,0,0,13.5,41.8,55.2,1858479,None
Ponsegromab,Tissue Adhesions,Tissue Adhesions,0,0,0,0,0,19.4,35.8,55.2,NA,None
Ponsegromab,Colon Polyps,Colon Polyps,0,0,0,0,0,19.9,35.2,55.1,1414772,None
Ponsegromab,Myxoma,Myxoma,0,0,0,0,0,23.8,31.3,55.1,222015,None
Ponsegromab,Chronic Graft Versus Host Disease (cGVHD),Chronic Graft Versus Host Disease (cGVHD),0,0,0,0,0,14.3,40.6,54.9,NA,None
Ponsegromab,Acute Limb Ischemia (ALI),Acute Limb Ischemia (ALI),0,0,0,0,0,12.1,42.7,54.8,581299,None
Ponsegromab,Leg Ulcer,Leg Ulcer,0,0,0,0,0,18.1,36.6,54.7,40326,None
Ponsegromab,Binge Drinking,Binge Drinking,0,0,0,0,0,8.2,46.4,54.6,440518,None
Ponsegromab,Hypoplastic Left Heart Syndrome,Hypoplastic Left Heart Syndrome,0,0,0,0,0,12.3,42.3,54.6,81849,None
Ponsegromab,Radiation Fibrosis Syndrome,Radiation Fibrosis Syndrome,0,0,0,0,0,27,27.6,54.6,NA,None
Ponsegromab,Hypoalbuminemia,Hypoalbuminemia,0,0,0,0,0,18.9,35.6,54.5,45890,None
Ponsegromab,Myocarditis,Myocarditis,0,0,0,0,0,9.8,44.6,54.5,60941,None
Ponsegromab,Bone and Joint Infections (BJIs),Bone and Joint Infections (BJIs),0,0,0,0,0,23.3,31,54.3,NA,None
Ponsegromab,Pediatric Acute Myeloid Leukemia (AML),Pediatric Acute Myeloid Leukemia (AML),0,0,0,0,0,9.3,44.9,54.3,NA,None
Ponsegromab,Rhinosinusitis,Rhinosinusitis,0,0,0,0,0,25.3,29,54.3,NA,None
Ponsegromab,Hirschsprung Disease,Hirschsprung Disease,0,0,0,0,0,23.9,30.2,54.1,81849,None
Ponsegromab,Hormone Receptor-Positive Breast Cancer,Hormone Receptor-Positive Breast Cancer,0,0,0,0,0,27.6,26.5,54.1,NA,None
Ponsegromab,Left Main Coronary Artery (LMCA) Disease,Left Main Coronary Artery (LMCA) Disease,0,0,0,0,0,7.4,46.7,54.1,8139256,None
Ponsegromab,Hypoproteinemia,Hypoproteinemia,0,0,0,0,0,18.8,35.1,54,45890,None
Ponsegromab,Traumatic Wounds,Traumatic Wounds,0,0,0,0,0,32.5,21.4,54,NA,None
Ponsegromab,Paranasal Sinus Diseases,Paranasal Sinus Diseases,0,0,0,0,0,25.4,28.5,53.9,2427708,None
Ponsegromab,Retroperitoneal Fibrosis,Retroperitoneal Fibrosis,0,0,0,0,0,26.3,27.6,53.9,NA,None
Ponsegromab,Swallowing Disorders / Dysphagia,Swallowing Disorders / Dysphagia,0,0,0,0,0,21.9,31.9,53.9,NA,None
Ponsegromab,Atrioventricular Block,Atrioventricular Block,0,0,0,0,0,19.1,34.6,53.7,NA,None
Ponsegromab,Prenatal Exposure Delayed Effects,Prenatal Exposure Delayed Effects,0,0,0,0,0,29.2,24.4,53.7,NA,None
Ponsegromab,Hematologic Complications in Pregnancy,Hematologic Complications in Pregnancy,0,0,0,0,0,11.1,42.4,53.5,244323,None
Ponsegromab,Late-Onset Thymidine Kinase 2 Deficiency (TK2D),Late-Onset Thymidine Kinase 2 Deficiency (TK2D),0,0,0,0,0,26.8,26.8,53.5,NA,None
Ponsegromab,Foot Ulcer,Foot Ulcer,0,0,0,0,0,18.7,34.7,53.4,40326,None
Ponsegromab,Multiple Endocrine Neoplasia,Multiple Endocrine Neoplasia,0,0,0,0,0,24.2,29.2,53.4,327,None
Ponsegromab,Hereditary Spherocytosis,Hereditary Spherocytosis,0,0,0,0,0,21.6,31.6,53.2,NA,None
Ponsegromab,Female Infertility,Female Infertility,0,0,0,0,0,15.1,38,53.1,1706849,None
Ponsegromab,Hereditary Elliptocytosis,Hereditary Elliptocytosis,0,0,0,0,0,21.4,31.7,53.1,81849,None
Ponsegromab,Cavernous Sinus Syndromes,Cavernous Sinus Syndromes,0,0,0,0,0,25.6,27.4,53,NA,None
Ponsegromab,Femur Head Necrosis,Femur Head Necrosis,0,0,0,0,0,29.4,23.6,53,NA,None
Ponsegromab,Hypothalamic Diseases,Hypothalamic Diseases,0,0,0,0,0,18.9,34.1,53,NA,None
Ponsegromab,Staphylococcus aureus,Staphylococcus aureus,0,0,0,0,0,11.2,41.8,53,3382912,None
Ponsegromab,Cerebrovascular Trauma,Cerebrovascular Trauma,0,0,0,0,0,19.9,33,52.9,1219359,None
Ponsegromab,Dissecting Aneurysm,Dissecting Aneurysm,0,0,0,0,0,21.7,31.1,52.8,150024,None
Ponsegromab,Hyperpituitarism,Hyperpituitarism,0,0,0,0,0,19.8,33.1,52.8,327,None
Ponsegromab,Malaria,Malaria,0,0,0,0,0,25.2,27.7,52.8,0,None
Ponsegromab,Meningitis,Meningitis,0,0,0,0,0,16.2,36.6,52.8,26733,None
Ponsegromab,Sebaceous Gland Diseases,Sebaceous Gland Diseases,0,0,0,0,0,31.9,20.8,52.8,38191,None
Ponsegromab,Low Tension Glaucoma,Low Tension Glaucoma,0,0,0,0,0,10.1,42.6,52.7,5025903,None
Ponsegromab,Constipation,Constipation,0,0,0,0,0,10.7,41.9,52.6,2937754,None
Ponsegromab,Hereditary Neoplastic Syndromes,Hereditary Neoplastic Syndromes,0,0,0,0,0,23.8,28.8,52.6,NA,None
Ponsegromab,Neurotoxicity Syndromes,Neurotoxicity Syndromes,0,0,0,0,0,13.2,39.4,52.6,3024163,None
Ponsegromab,Glycosuria,Glycosuria,0,0,0,0,0,26.6,26,52.5,NA,None
Ponsegromab,Thrombocytosis,Thrombocytosis,0,0,0,0,0,11.2,41.2,52.4,244323,None
Ponsegromab,Alcohol Use Disorder (AUD),Alcohol Use Disorder (AUD),0,0,0,0,0,29.1,23.2,52.3,NA,None
Ponsegromab,Epiretinal Membrane,Epiretinal Membrane,0,0,0,0,0,12.7,39.6,52.3,2767515,None
Ponsegromab,Pleural Effusion,Pleural Effusion,0,0,0,0,0,10.4,41.8,52.2,NA,None
Ponsegromab,Postmenopausal Osteoporosis,Postmenopausal Osteoporosis,0,0,0,0,0,16.4,35.8,52.2,4009211,None
Ponsegromab,Central Nervous System Bacterial Infections,Central Nervous System Bacterial Infections,0,0,0,0,0,10.6,41.3,51.9,1944266,None
Ponsegromab,Multiple Endocrine Neoplasia Type 2 (MEN2),Multiple Endocrine Neoplasia Type 2 (MEN2),0,0,0,0,0,25.6,26.3,51.9,NA,None
Ponsegromab,Uremia,Uremia,0,0,0,0,0,13.9,38,51.9,724456,None
Ponsegromab,Encephalitis,Encephalitis,0,0,0,0,0,15,36.7,51.8,9809,None
Ponsegromab,Mosquito-Borne Diseases,Mosquito-Borne Diseases,0,0,0,0,0,29.6,22.1,51.7,NA,None
Ponsegromab,Acute Spinal Cord Injury,Acute Spinal Cord Injury,0,0,0,0,0,18.4,33.2,51.6,NA,None
Ponsegromab,Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy (HSCT-TMA),Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy (HSCT-TMA),0,0,0,0,0,14.8,36.7,51.5,NA,None
Ponsegromab,Occupational Diseases,Occupational Diseases,0,0,0,0,0,34.4,17,51.5,NA,None
Ponsegromab,Pituitary Diseases,Pituitary Diseases,0,0,0,0,0,19.1,32.4,51.5,NA,None
Ponsegromab,Stress Fractures,Stress Fractures,0,0,0,0,0,20.5,31,51.4,NA,None
Ponsegromab,Helminthiasis,Helminthiasis,0,0,0,0,0,34.1,17.1,51.3,NA,None
Ponsegromab,Psoriatic Arthritis (PsA),Psoriatic Arthritis (PsA),0,0,0,0,0,10.3,41,51.3,1550095,None
Ponsegromab,Brain Atrophy,Brain Atrophy,0,0,0,0,0,11.8,39.5,51.2,NA,None
Ponsegromab,Kawasaki Disease (Mucocutaneous Lymph Node Syndrome),Kawasaki Disease (Mucocutaneous Lymph Node Syndrome),0,0,0,0,0,16.4,34.9,51.2,NA,None
Ponsegromab,Nematode Infections,Nematode Infections,0,0,0,0,0,32.4,18.8,51.2,0,None
Ponsegromab,Barrett's Esophagus,Barrett's Esophagus,0,0,0,0,0,13.8,37.2,51.1,758169,None
Ponsegromab,Developmental Defects of Enamel,Developmental Defects of Enamel,0,0,0,0,0,25.5,25.5,51,NA,None
Ponsegromab,Prostatitis,Prostatitis,0,0,0,0,0,18.8,32.1,50.9,117729,None
Ponsegromab,Ankylosis,Ankylosis,0,0,0,0,0,22.9,27.9,50.8,327,None
Ponsegromab,Uveal Diseases,Uveal Diseases,0,0,0,0,0,27.8,23,50.8,NA,None
Ponsegromab,Hirsutism,Hirsutism,0,0,0,0,0,19.6,30.9,50.5,NA,None
Ponsegromab,Exanthema,Exanthema,0,0,0,0,0,10.8,39.6,50.4,4343061,None
Ponsegromab,Zika Virus Infection,Zika Virus Infection,0,0,0,0,0,11.4,39,50.4,14,None
Ponsegromab,Gastric Ulcer,Gastric Ulcer,0,0,0,0,0,19,31.4,50.3,457800,None
Ponsegromab,Esophageal Adenocarcinoma,Esophageal Adenocarcinoma,0,0,0,0,0,20.8,29.3,50.1,NA,None
Ponsegromab,Alopecia Areata,Alopecia Areata,0,0,0,0,0,12.2,37.8,50,1252817,None
Ponsegromab,Chronic Insomnia,Chronic Insomnia,0,0,0,0,0,22.1,27.9,50,169200,None
Ponsegromab,Pericarditis,Pericarditis,0,0,0,0,0,11.6,38.4,50,NA,None
Ponsegromab,Stent Thrombosis,Stent Thrombosis,0,0,0,0,0,25.8,24.2,50,NA,None
Ponsegromab,Endometrial Hyperplasia,Endometrial Hyperplasia,0,0,0,0,0,22,28,49.9,156745,None
Ponsegromab,Gastrointestinal (GI) Bleeding,Gastrointestinal (GI) Bleeding,0,0,0,0,0,8.7,41.2,49.9,1215297,None
Ponsegromab,Infectious Skin Diseases,Infectious Skin Diseases,0,0,0,0,0,9.9,39.9,49.8,1909479,None
Ponsegromab,Relapsed/Refractory Multiple Myeloma,Relapsed/Refractory Multiple Myeloma,0,0,0,0,0,11.1,38.6,49.8,NA,None
Ponsegromab,Interstitial Lung Disease-Associated Pulmonary Hypertension (ILD-PH),Interstitial Lung Disease-Associated Pulmonary Hypertension (ILD-PH),0,0,0,0,0,15.5,34.2,49.7,NA,None
Ponsegromab,Transthyretin Amyloid Cardiomyopathy (ATTR-CM),Transthyretin Amyloid Cardiomyopathy (ATTR-CM),0,0,0,0,0,10.5,39.2,49.7,NA,None
Ponsegromab,Gram-Negative ESKAPE Pathogens,Gram-Negative ESKAPE Pathogens,0,0,0,0,0,29,20.6,49.6,NA,None
Ponsegromab,Tooth Abnormalities,Tooth Abnormalities,0,0,0,0,0,23.2,26.4,49.6,27806,None
Ponsegromab,Lymphatic Vessel Tumors,Lymphatic Vessel Tumors,0,0,0,0,0,7.9,41.6,49.5,205372,None
Ponsegromab,Coccidiosis,Coccidiosis,0,0,0,0,0,23.4,25.9,49.4,NA,None
Ponsegromab,Nonfermenting Gram-Negative Bacteria (NFGNB),Nonfermenting Gram-Negative Bacteria (NFGNB),0,0,0,0,0,28.9,20.6,49.4,NA,None
Ponsegromab,Osteopenia,Osteopenia,0,0,0,0,0,9.1,40.3,49.4,1523561,None
Ponsegromab,Mandibular Diseases,Mandibular Diseases,0,0,0,0,0,20.3,29,49.3,NA,None
Ponsegromab,Macular Hole,Macular Hole,0,0,0,0,0,11.2,38,49.2,2767515,None
Ponsegromab,Retinitis,Retinitis,0,0,0,0,0,24.2,24.8,49.1,81849,None
Ponsegromab,Limbic Encephalitis,Limbic Encephalitis,0,0,0,0,0,21.4,27.6,49,NA,None
Ponsegromab,Peripheral Spondyloarthritis (SpA),Peripheral Spondyloarthritis (SpA),0,0,0,0,0,20.5,28.5,49,NA,None
Ponsegromab,Thrombotic Microangiopathy,Thrombotic Microangiopathy,0,0,0,0,0,9.5,39.5,49,NA,None
Ponsegromab,Toxoplasmosis,Toxoplasmosis,0,0,0,0,0,21.7,27.3,49,327397,None
Ponsegromab,Heart Block,Heart Block,0,0,0,0,0,15.3,33.6,48.8,16370,None
Ponsegromab,Infectious Complications in Pregnancy,Infectious Complications in Pregnancy,0,0,0,0,0,26.7,21.9,48.6,NA,None
Ponsegromab,Plasmacytoma,Plasmacytoma,0,0,0,0,0,11.8,36.8,48.6,1637,None
Ponsegromab,Endogenous Cushing's Syndrome,Endogenous Cushing's Syndrome,0,0,0,0,0,11.2,36.8,48,1637,None
Ponsegromab,Retinal Perforations,Retinal Perforations,0,0,0,0,0,14,33.8,47.8,673356,None
Ponsegromab,Diamond-Blackfan Anemia,Diamond-Blackfan Anemia,0,0,0,0,0,21.3,26.4,47.7,1637,None
Ponsegromab,Alopecia,Alopecia,0,0,0,0,0,10.6,36.9,47.5,627742,None
Ponsegromab,Hair Diseases,Hair Diseases,0,0,0,0,0,17.8,29.8,47.5,NA,None
Ponsegromab,Hypotrichosis,Hypotrichosis,0,0,0,0,0,10.6,36.9,47.5,327,None
Ponsegromab,Oral Leukoplakia,Oral Leukoplakia,0,0,0,0,0,10.9,36.5,47.4,429740,None
Ponsegromab,Pregnancy in Diabetics,Pregnancy in Diabetics,0,0,0,0,0,17.2,29.9,47.1,NA,None
Ponsegromab,Bundle-Branch Block,Bundle-Branch Block,0,0,0,0,0,19.1,28,47,NA,None
Ponsegromab,Ankylosing Spondylitis (AS),Ankylosing Spondylitis (AS),0,0,0,0,0,16.5,30.4,46.8,NA,None
Ponsegromab,Psychotic Disorders,Psychotic Disorders,0,0,0,0,0,18.1,28.7,46.8,NA,None
Ponsegromab,Cutaneous Scar,Cutaneous Scar,0,0,0,0,0,25.8,20.9,46.7,NA,None
Ponsegromab,Central Nervous System Viral Diseases,Central Nervous System Viral Diseases,0,0,0,0,0,14.5,32,46.4,NA,None
Ponsegromab,Interstitial Nephritis,Interstitial Nephritis,0,0,0,0,0,8.8,37.6,46.4,327,None
Ponsegromab,Blood Vessel Dissection,Blood Vessel Dissection,0,0,0,0,0,21.6,24.7,46.3,NA,None
Ponsegromab,Hypopigmentation,Hypopigmentation,0,0,0,0,0,9.4,36.9,46.3,494158,None
Ponsegromab,Indolent Lymphomas,Indolent Lymphomas,0,0,0,0,0,10,36.3,46.3,NA,None
Ponsegromab,Retinal Detachment,Retinal Detachment,0,0,0,0,0,12.3,33.8,46.1,673356,None
Ponsegromab,Barth Syndrome,Barth Syndrome,0,0,0,0,0,12,33.9,46,1637,None
Ponsegromab,Chronic Bronchitis,Chronic Bronchitis,0,0,0,0,0,11.4,34.5,45.9,1834170,None
Ponsegromab,Complicated Urinary Tract Infections (cUTI),Complicated Urinary Tract Infections (cUTI),0,0,0,0,0,24.1,21.6,45.8,NA,None
Ponsegromab,Cicatrix / Scar,Cicatrix / Scar,0,0,0,0,0,20.4,25.4,45.7,NA,None
Ponsegromab,Hereditary Autoinflammatory Diseases,Hereditary Autoinflammatory Diseases,0,0,0,0,0,16.8,28.9,45.7,NA,None
Ponsegromab,Leukoplakia,Leukoplakia,0,0,0,0,0,10.3,35.3,45.6,429740,None
Ponsegromab,Rhinitis,Rhinitis,0,0,0,0,0,27.2,18.4,45.6,NA,None
Ponsegromab,Panuveitis,Panuveitis,0,0,0,0,0,16,29.4,45.4,327,None
Ponsegromab,Peptic Ulcer,Peptic Ulcer,0,0,0,0,0,15.4,29.9,45.3,498286,None
Ponsegromab,Transfusion Dependent Adult Thalassemias,Transfusion Dependent Adult Thalassemias,0,0,0,0,0,14.2,31.1,45.3,NA,None
Ponsegromab,Photosensitivity Disorders,Photosensitivity Disorders,0,0,0,0,0,16.5,28.7,45.2,NA,None
Ponsegromab,Arteritis,Arteritis,0,0,0,0,0,10.6,34.4,45,150024,None
Ponsegromab,Erythema Infectiosum,Erythema Infectiosum,0,0,0,0,0,12.8,32.2,45,284820,None
Ponsegromab,Hypervolemia (Fluid Overload),Hypervolemia (Fluid Overload),0,0,0,0,0,22.1,22.9,45,NA,None
Ponsegromab,Vitiligo,Vitiligo,0,0,0,0,0,9.6,35.3,44.9,NA,None
Ponsegromab,Treatment-Resistant Depression (TRD),Treatment-Resistant Depression (TRD),0,0,0,0,0,14,30.9,44.8,NA,None
Ponsegromab,Uncontrolled Hypertension (incl. RHTN),Uncontrolled Hypertension (incl. RHTN),0,0,0,0,0,11.5,33.3,44.8,NA,None
Ponsegromab,Jaw Diseases,Jaw Diseases,0,0,0,0,0,17,27.8,44.7,NA,None
Ponsegromab,Acute Aortic Syndrome,Acute Aortic Syndrome,0,0,0,0,0,19.8,24.8,44.6,NA,None
Ponsegromab,Experimental Radiation Injuries,Experimental Radiation Injuries,0,0,0,0,0,16.1,28.4,44.6,NA,None
Ponsegromab,Prolactinoma,Prolactinoma,0,0,0,0,0,9.7,34.7,44.4,245548,None
Ponsegromab,Crush Injuries,Crush Injuries,0,0,0,0,0,15.1,29.2,44.3,NA,None
Ponsegromab,Healthcare-Associated Infections,Healthcare-Associated Infections,0,0,0,0,0,12.5,31.8,44.3,662991,None
Ponsegromab,Acute Graft Versus Host Disease (aGVHD),Acute Graft Versus Host Disease (aGVHD),0,0,0,0,0,11.8,32.4,44.2,NA,None
Ponsegromab,Hospital-Acquired Infections,Hospital-Acquired Infections,0,0,0,0,0,12.6,31.6,44.2,662991,None
Ponsegromab,Protozoan Infections,Protozoan Infections,0,0,0,0,0,24,20.2,44.2,NA,None
Ponsegromab,B-Cell Leukemia,B-Cell Leukemia,0,0,0,0,0,8.3,35.8,44.1,NA,None
Ponsegromab,Chronic Lymphocytic Leukemia (CLL),Chronic Lymphocytic Leukemia (CLL),0,0,0,0,0,8.3,35.8,44.1,116026,None
Ponsegromab,Erythema Nodosum,Erythema Nodosum,0,0,0,0,0,19.7,24.4,44.1,NA,None
Ponsegromab,Arbovirus Infections,Arbovirus Infections,0,0,0,0,0,12,32,44,NA,None
Ponsegromab,Flavivirus Infections,Flavivirus Infections,0,0,0,0,0,11.6,32.1,43.7,NA,None
Ponsegromab,Multidrug-Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,0,0,0,0,0,6.6,37.2,43.7,162,None
Ponsegromab,Pleural Diseases,Pleural Diseases,0,0,0,0,0,9.3,34.4,43.7,NA,None
Ponsegromab,Epstein-Barr Virus (EBV),Epstein-Barr Virus (EBV),0,0,0,0,0,7.7,35.9,43.6,80253,None
Ponsegromab,Pelvic Inflammatory Disease,Pelvic Inflammatory Disease,0,0,0,0,0,16.3,27.3,43.6,NA,None
Ponsegromab,Bacterial Meningitis,Bacterial Meningitis,0,0,0,0,0,10.8,32.7,43.4,NA,None
Ponsegromab,Peritonitis,Peritonitis,0,0,0,0,0,16.3,27.1,43.4,NA,None
Ponsegromab,Hypogonadism,Hypogonadism,0,0,0,0,0,12.5,30.6,43.1,931883,None
Ponsegromab,Lymphangiomyoma,Lymphangiomyoma,0,0,0,0,0,10.3,32.8,43.1,1637,None
Ponsegromab,Overdose,Overdose,0,0,0,0,0,20.3,22.8,43.1,NA,None
Ponsegromab,Bronchitis,Bronchitis,0,0,0,0,0,8.4,34.6,43,4061706,None
Ponsegromab,Patent Ductus Arteriosus,Patent Ductus Arteriosus,0,0,0,0,0,13.6,29.4,43,NA,None
Ponsegromab,Reinjuries,Reinjuries,0,0,0,0,0,15.7,27.3,43,NA,None
Ponsegromab,Acquired Hemolytic Anemias,Acquired Hemolytic Anemias,0,0,0,0,0,12.1,30.8,42.9,NA,None
Ponsegromab,Pituitary ACTH Hypersecretion,Pituitary ACTH Hypersecretion,0,0,0,0,0,11.8,31.1,42.9,NA,None
Ponsegromab,Polyuria,Polyuria,0,0,0,0,0,14.5,28.2,42.7,576949,None
Ponsegromab,Rheumatic Fever,Rheumatic Fever,0,0,0,0,0,20.3,22.4,42.6,327397,None
Ponsegromab,Pulmonary Valve Insufficiency,Pulmonary Valve Insufficiency,0,0,0,0,0,11.3,31.3,42.5,NA,None
Ponsegromab,Perivascular Epithelioid Cell Neoplasms,Perivascular Epithelioid Cell Neoplasms,0,0,0,0,0,11.5,30.9,42.4,327,None
Ponsegromab,Viral Skin Diseases,Viral Skin Diseases,0,0,0,0,0,10.9,31.6,42.4,12993530,None
Ponsegromab,Autoimmune Cytopenias,Autoimmune Cytopenias,0,0,0,0,0,12.7,29.6,42.3,NA,None
Ponsegromab,Aortic Valve Insufficiency,Aortic Valve Insufficiency,0,0,0,0,0,7,35.1,42.2,75729,None
Ponsegromab,Occupational Dermatitis,Occupational Dermatitis,0,0,0,0,0,11,31,42,1484202,None
Ponsegromab,Treatment-Resistant Hypertension (RHTN),Treatment-Resistant Hypertension (RHTN),0,0,0,0,0,11.6,30.4,42,NA,None
Ponsegromab,Cerebral Palsy,Cerebral Palsy,0,0,0,0,0,8.8,33.2,41.9,115599,None
Ponsegromab,Peritoneal Diseases,Peritoneal Diseases,0,0,0,0,0,11.2,30.7,41.9,NA,None
Ponsegromab,Stomatognathic System Abnormalities,Stomatognathic System Abnormalities,0,0,0,0,0,19.8,21,40.8,NA,None
Ponsegromab,Hypercalcemia,Hypercalcemia,0,0,0,0,0,18.4,22,40.4,296860,None
Ponsegromab,Inherited Cardiac Conditions,Inherited Cardiac Conditions,0,0,0,0,0,9.2,31,40.2,NA,None
Ponsegromab,Adrenocortical Hyperfunction,Adrenocortical Hyperfunction,0,0,0,0,0,15,25,40,NA,None
Ponsegromab,Starvation,Starvation,0,0,0,0,0,10.6,29.4,40,NA,None
Ponsegromab,Supratentorial Neoplasms,Supratentorial Neoplasms,0,0,0,0,0,8.4,31.5,40,NA,None
Ponsegromab,Septic Shock,Septic Shock,0,0,0,0,0,12.6,27.3,39.9,NA,None
Ponsegromab,Pituitary Tumor,Pituitary Tumor,0,0,0,0,0,9.6,29.6,39.1,1637,None
Ponsegromab,Diabetes Insipidus,Diabetes Insipidus,0,0,0,0,0,12.3,26.7,39,NA,None
Ponsegromab,Tardive Dyskinesia,Tardive Dyskinesia,0,0,0,0,0,14.6,24,38.6,NA,None
Ponsegromab,Graft versus Host Disease (GvHD),Graft versus Host Disease (GvHD),0,0,0,0,0,12.4,26.1,38.5,NA,None
Ponsegromab,Metabolic Dysfunction-Associated Alcoholic Liver Disease (MetALD),Metabolic Dysfunction-Associated Alcoholic Liver Disease (MetALD),0,0,0,0,0,11.7,26.7,38.4,NA,None
Ponsegromab,Hypothalamic Neoplasms,Hypothalamic Neoplasms,0,0,0,0,0,8.5,29.7,38.2,2121796,None
Ponsegromab,Lymphangioleiomyomatosis,Lymphangioleiomyomatosis,0,0,0,0,0,10.4,27.9,38.2,1637,None
Ponsegromab,Axial Spondyloarthritis (axSpA),Axial Spondyloarthritis (axSpA),0,0,0,0,0,16.1,21.9,38.1,NA,None
Ponsegromab,Nephrogenic Diabetes Insipidus,Nephrogenic Diabetes Insipidus,0,0,0,0,0,11.7,26.1,37.8,1637,None
Ponsegromab,Alcoholic Fatty Liver,Alcoholic Fatty Liver,0,0,0,0,0,11.6,26,37.6,NA,None
Ponsegromab,Uveitis,Uveitis,0,0,0,0,0,13.3,23.8,37.2,81849,None
Ponsegromab,Extrapulmonary Tuberculosis,Extrapulmonary Tuberculosis,0,0,0,0,0,25.3,11.5,36.8,NA,None
Ponsegromab,Chronic Brain Damage,Chronic Brain Damage,0,0,0,0,0,9.9,26.7,36.6,NA,None
Ponsegromab,Pulmonary Valve Diseases,Pulmonary Valve Diseases,0,0,0,0,0,8.1,28.1,36.1,NA,None
Ponsegromab,Tracheal Diseases,Tracheal Diseases,0,0,0,0,0,11.6,23.9,35.4,NA,None
Ponsegromab,Primary Graft Dysfunction,Primary Graft Dysfunction,0,0,0,0,0,10.7,24.4,35.1,NA,None
Ponsegromab,Anterior Uveitis,Anterior Uveitis,0,0,0,0,0,16.9,17.8,34.7,NA,None
Ponsegromab,Taste Disorders,Taste Disorders,0,0,0,0,0,9.5,25.1,34.5,NA,None
Ponsegromab,Transfusion Reaction,Transfusion Reaction,0,0,0,0,0,18.4,15.9,34.3,NA,None
Ponsegromab,"Pituitary Neuroendocrine Tumors (Pituitary Adenomas, PitNETs)","Pituitary Neuroendocrine Tumors (Pituitary Adenomas, PitNETs)",0,0,0,0,0,8,26.2,34.2,NA,None
Ponsegromab,Extraintestinal Pathogenic Escherichia Coli (ExPEC),Extraintestinal Pathogenic Escherichia Coli (ExPEC),0,0,0,0,0,17,16.8,33.8,NA,None
Ponsegromab,Multiple Trauma,Multiple Trauma,0,0,0,0,0,9.4,24.4,33.8,NA,None
Ponsegromab,Thyroid Nodule,Thyroid Nodule,0,0,0,0,0,10.5,23,33.5,864685,None
Ponsegromab,Hyperaldosteronism,Hyperaldosteronism,0,0,0,0,0,6.2,26.9,33.1,NA,None
Ponsegromab,Megaloblastic Anemia,Megaloblastic Anemia,0,0,0,0,0,10.8,22,32.8,NA,None
Ponsegromab,Stomatitis,Stomatitis,0,0,0,0,0,9.5,22.7,32.2,NA,None
Ponsegromab,Arm Injuries,Arm Injuries,0,0,0,0,0,4.7,27.2,31.8,NA,None
Ponsegromab,Contact Dermatitis,Contact Dermatitis,0,0,0,0,0,5.8,25.1,30.9,6840620,None
Ponsegromab,Gram-Positive ESKAPE Pathogens,Gram-Positive ESKAPE Pathogens,0,0,0,0,0,11.2,19.4,30.6,NA,None
Ponsegromab,Wrist Injuries,Wrist Injuries,0,0,0,0,0,5.6,23.1,28.7,NA,None
Ponsegromab,Wrist Fractures,Wrist Fractures,0,0,0,0,0,6,22.3,28.3,NA,None
Ponsegromab,Forearm Injuries,Forearm Injuries,0,0,0,0,0,5.6,22.5,28.1,NA,None
Ponsegromab,Radius Fractures,Radius Fractures,0,0,0,0,0,5.3,22.8,28,NA,None
Ponsegromab,Meningeal Tuberculosis,Meningeal Tuberculosis,0,0,0,0,0,10.3,15.3,25.6,NA,None
Ponsegromab,Central Nervous System Tuberculosis,Central Nervous System Tuberculosis,0,0,0,0,0,10,15,24.9,NA,None
